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ABSTRACT 
Background: Unsafe abortion is estimated to cause around 23000 maternal deaths yearly, 
most of those deaths are preventable by proper use of contraception and access to safe 
abortion. Barriers to access to safe abortion include legal frameworks, infrastructure and 
shortage of eligible and trained providers. Lack of knowledge, stigma and cultural aspects 
influence women’s abortion-seeking behavior. 
Aim: The overall aim of this thesis is to study factors that influence access to comprehensive 
abortion care focusing on increasing provider availability in different settings. 
Materials, methods and results 
Study I: A cross sectional survey including 1996 medical students found that disallowing 
attitudes and misconceptions were common. Very few had any clinical practice in abortion 
care. It is important to improve medical education and clinical training in abortion care 
services to influence medical student’s attitudes and ensure their future abortion provision. 
Study II: In-depth interviews were conducted with 23 medical students using a topic guide. 
Thematic analysis with an inductive approach was used to analyze data. Participants 
described a fear to provide abortion in their future practice, and their understanding of the law 
was limited. They also had limited clinical experience and were influenced by societal 
tradition and norm. Improved medical education including clinical practice is needed to 
increase the possibility that today’s medical students will become tomorrow’s abortion 
providers. 
Study III: A cost-effectiveness analysis was conducted alongside a randomized controlled 
equivalence trial to determine the cost-effectiveness of nurse-midwife provision of medical 
abortion compared with physicians. Average direct costs were EUR 45 for the nurse-midwife 
group and EUR 58 for the physician group. Increased effectiveness of the intervention gave 
an ICER at EUR -831 for direct costs and of EUR-1769 for total costs per avoided surgical 
intervention. 
Study IV: A systematic review was undertaken assess the effectiveness, safety and 
acceptability of non-physician provision of early medical abortion care including medical 
treatment for incomplete abortion. Electronic databases were searched using a search strategy 
based on PICOs. Six publications were included. Medical abortion by non-physicians using 
misoprostol regimens is equally effective as treatment by physicians. Acceptability among 
women, measured as overall satisfaction, is similar between groups. Quality of evidence 
range from low to moderate. 
 
Conclusion: Provider availability is an important component for abortion access. It is 
important to focus on curricula for medical students and include abortion care to reduce 
stigma and ensure future provider availability. Midlevel provision of medical abortion is cost-
effective, effective and acceptable to women. Thus task-shifting is a way to increase access to 
safe abortion.  In order to truly improve access to safe abortion care, increased knowledge is 
needed among providers and women.  
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DEFINITIONS 
Comprehensive  
Abortion Care (CAC) 
Comprehensive safe abortion care encompasses the provision of 
elective abortion services at the request of the woman, along with 
counseling for contraceptive use, medical after-care, and attention o 
other issues that are relevant to the woman’s health 
Fecundity The ability to produce offspring 
Maternal death Death of a woman while pregnant or within 42 days of termination 
of pregnancy, irrespective of the duration and site of the pregnancy, 
from any cause related to or aggravated by the pregnancy or its 
management but not from accidental or incidental causes (WHO 
2012) 
Maternal Mortality Ratio Number of deaths per 100000 live births 
Sex ratio Number of females per 1000 males 
Total Fertility Rate the average number of children that would be born to a woman over 
her lifetime should she survive from birth to the end of her 
reproductive life 
Unmet need (for family 
planning) 
Fecund and sexually active women wishing to limit or postpone 
child birth, but don’t use contraception 
Unsafe abortion The termination of an unwanted pregnancy, either by persons 
lacking the necessary skills or in an environment lacking minimal 
medical standards or both (WHO) 
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1 INTRODUCTION 
Women have been subject to unplanned pregnancies since the beginning of times. Dealing 
with such pregnancies has caused substantial morbidity and mortality. During the last 
centuries women have been increasingly empowered in most societies and important 
advances has been made to enhance women’s rights and life conditions. Important scientific 
advances have also been made in the field of reproductive health and rights with development 
of contraceptive methods as well as methods of safe abortion. This increased knowledge and 
awareness as well as changes in the legal framework has contributed to decreased maternal 
mortality caused by unplanned pregnancies and unsafe abortion, especially in high income 
countries and where the legal framework is permitting, but also increasingly so in lower 
income settings. Despite this progress access to abortion and contraception remains 
controversial in a global perspective and numbers of preventable maternal deaths are still 
high. Access to safe abortion has yet to reach its full potential. 
1.1 HISTORY 
1.1.1 Family planning 
For as long as there are records, societies have wished to limit number of pregnancies for the 
individual, and to regulate population growth on a societal level. Ancient Greeks were 
worried that limitations of pregnancies would endanger population growth. Aristotle stated 
that a nation should not have more people than it can provide for. In 1798 an English 
clergyman, Thomas Malthus, stated that the worlds’ population needed to be limited, for 
instance by delayed marriage or celibacy, otherwise food supplies would run out. He believed 
natural disasters, disease, and war are needed to limit population growth. Although massively 
criticized, his theory laid ground for the modern discourse about population growth. During 
the industrial revolution from approximately 1750 to 1900, populations grew immensely in 
the industrialized world, and the population of England increased from 6 to 33 million. The 
second half of the 19th century saw a decline in fertility rates in England most likely due to 
increased practice of traditional methods of birth control such as abstinence and withdrawal 
(Drife, 2010) (Schenker et al., 1993). The birth control movement was started in 1831 by 
Robert Owen and the first family planning clinics were opened by Margret Sanger in the US 
in 1916 and Marie Stopes in the United Kingdom. 
Entering the second half of the 20th century, concerns about a growing global population and 
the threat of decreasing food supplies set the tone of the global debate. Population reduction 
was seen as necessary means to limit poverty and enhance economic growth. These thoughts 
fueled the medical development of contraception and abortion (Green). Women’s rights 
groups were positive to contraception and recognized its potential to reduce maternal 
mortality, but questioned the population control thoughts. At the time of the International 
Conference on Population and Development (ICPD) in Mexico City in 1984 the abortion 
climate changed as the United States administration declared prohibition of funding for 
organizations outside of the US providing abortions (Boyle et al., 2015). 
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The ICPD in Cairo 1994 was the start of a new era of relationships between population, 
development and individual well-being (UNFPA, 2014). The conference defined and 
accepted a concept of reproductive rights. The agreement was signed by 179 countries 
showing their commitment to prevent unsafe abortion. 
The United Nations has declared access to sexual and reproductive health and contraception a 
human right interrelated to other basic human rights, including the right to life and the right to 
health. 
1.1.2 Overview of the development of contraceptive methods 
The use of contraception and protection against sexually transmitted disease was a privilege 
of the upper classes until the beginning of the 19th century. That population declined during 
the Roman Empire declined despite ample supplies of food suggests methods of fertility 
control was used. Coitus interruptus is mentioned at least twice in the Old Testament and was 
likely to have been practiced in the Greek as well as Roman societies (Genesis 38:8-10). The 
use of male protection was first described by the Persian physician Al-Akhawayni, and a 
condom made from sheep intestines was described as means to protect oneself against 
Syphilis by the English physician Turner in 1717. With the discovery of vulcanization, that 
turns crude rubber into an elastic material, condoms became increasingly popular and from 
around 1870s more widespread in the western society (Amy et al., 2015).  
In the early 19th century several vaginal devices were developed, and in 1846 the first US 
patent for a pessary was granted. The intrauterine device (IUD) was first described in 1909 
and an intrauterine ring was developed in Germany by Dr Gräfenberg in the late 1920s. 
Further development of the intra uterine ring was undertaken in Japan by Dr Ota. Plastic 
IUDs were developed in the 1940s which improved insertion and retrieval. In 1969, copper 
IUDs were introduced and in 1977 the first gestagen intrauterine device was introduced 
(Thiery, 1997). This was followed by the Population Council’s development of the 
levonorgestrel releasing intrauterine system, which was first approved in Finland in 1990. In 
1937 it was shown that progesterone inhibits ovulation in rabbits and in 1951 the first 
synthetic progesterone norethindrone was registered, shortly thereafter followed by 
Norethynodrel in 1953. In 1955 scientists Pincus and Chang announced successful inhibition 
of ovulation using those substances in women at a meeting of the International Planned 
Parenthood Federation. Clinical trials with a combined pill containing Norethynodrel and 
estrogen started in Puerto Rico, where the legislation allowed information on prevention of 
conception. In 1957 Enovid, the first combined oral contraceptive pill was sold in the United 
States to treat “menstrual disorders” (Connell, 1999). In 1964 the combined pill was 
registered in Sweden also for treatment of menstrual disorders.  
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Figure 1.1.2 Development of modern contraceptives, adapted from (Connell, 1999). 
1.1.3 Abortion 
1.1.3.1 Methods 
Reports from ancient societies describe an array of medical methods of abortion including 
vaginal use of honey and dates in ancient Egypt and herbs or mercury in China. It is unclear 
how effective the methods were (Drife, 2010). However, recent studies from rural low-
income settings have shown that traditional herbs used to provoke abortion have strong 
uterotonic properties (Nikolajsen et al., 2011). Hippocrates suggested that physical exercise 
could cause abortion. Surgical methods using dilatators made of wood, bone or ivory were 
described in the 2ond century. In 1844 Laminaria, a Japanese seaweed, was introduced as a 
cervical dilatator, and in 1723 Garengot described the first curette. Recamier, who is  
considered the founder of Gynecology, used the curette to evacuate the uterus for the first 
time in1843 (Lund, 1953). Women and backstreet abortionists have used sharp objects and 
instruments in the uterus since the middle ages (Public Health Currents, 1971). In the 19th 
century the practice of Dilatation and Curettage started, and the Irish physician James Young 
Simpson described vacuum aspiration. The latter was developed in Russia during the period 
with liberal abortion laws in the 1920s, and the introduction of the flexible Karman cannula 
in the 1970s reduced the risk of perforation of the uterus. 
In 1970 intravenous and subcutaneous prostaglandin was reported to have abortive effect in 
the second trimester (Roth-Brandel et al., 1970). Shortly thereafter high effects of the 
prostaglandin in early pregnancy was reported, and the effect was ameliorated after 
intrauterine administration of the prostaglandin was introduced (Wiqvist et al., 1970). The 
progesterone antagonist Mifepristone (RU 486) was shown to potentiate the effect of 
prostaglandin in the early 1980s. The combined method resulted in 94% complete abortions 
for gestational lengths of 49 days or less (Bygdeman et al., 1985).  
1.1.3.2 Attitudes to abortion 
Attitudes toward abortion have varied in different societies and over time. Aristotele stated 
that abortion was acceptable until “quickening” i.e. feeling of fetal movement. This view was 
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common until the early 19th century. During the middle ages women’s status declined, 
midwives providing abortion services could be procured as witches(Joffe, 1999). 
Attitudes to abortion fluctuate over time. By the turn of the 18th century abortion was legal, or 
at least not illegal, in the UK as well as in the United States. During the Victorian era many 
countries undergoing industrialization limited abortion (Potts, 1979). 
Religion is an important factor influencing attitudes to abortion in a society. In Judaism 
abortion is accepted if the woman’s life is threatened or if she has been subject to rape. In 
Roman Catholicism all abortion is considered termination of human life. This belief stems 
from the theory that the purpose of sexuality is reproduction. In the 1930 Pope Pius XI 
declared total prohibition of birth control methods, a view that still persists. David Maguire, 
theologian and professor of ethics recalls that the catholic church has a long history of 
accepting abortions under certain circumstances influenced by the idea of ‘ensoulment’. In 
the 13th century, St Thomas Aquinas, a proponent of the ‘natural law’ theory of Aristotle, 
agreed that populations should be limited to those that it can provide for. In the 15th century, 
St Antoninus, the arch-bishop of Florence, said abortion was justified to save the woman’s 
life. The Jesuit Thomas Sanchez, who was the leading catholic theologian in the mid 16th 
century, wrote important works on matrimony. He considered that abortion could be accepted 
in case there were physical threats to the woman. Abortion was also justified should an 
unmarried woman risk ruined reputation, (Catholics for Choice, 2014). In November 2016, 
the current pope Francis gave all catholic priests permission to forgive abortion. 
Protestantism generally allows a couple to decide in matters of family planning and 
contraception. Abortion is generally accepted if the mother’s life is threatened and liberal 
protestants accepts abortion at the woman’s discretion (Pinter et al., 2016).  
The eastern orthodox church recognizes sexual intercourse as an expression of love and 
allows a married couple to make decisions regarding contraception although abortion and 
permanent sterilization has been condemned. In Islam there are many interpretations of what 
is acceptable in relation to abortion and contraception. A sexual relationship to satisfy a 
couple’s needs is permitted in a legitimate relationship. Contraception is permitted under 
certain circumstances including spacing and where there is a fear of the mental and physical 
well-being of the mother as well as personal reasons. Vasectomy is prohibited but female 
sterilization is permitted should the woman’s health be endangered. Early abortion is broadly 
acceptable if there is a legitimate reason (Shapiro, 2014). In Sikhism contraception is broadly 
accepted but abortion prohibited except to save the mother’s life or in case of rape. Hinduism 
permits all methods of contraception, and abortion is legal in India on broad grounds. 
Buddhism is open to family planning and contraception, abortion can be accepted depending 
on the motive, it can be a means to save the mother (Christopher et al., 2006). 
1.1.3.3 Legalization of abortion 
In 1803 Great Britain expanded its anti-abortion law to include surgical abortion and during 
the 19th century many countries followed suit and implemented anti-abortion laws where 
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abortion previously had been permitted or at least not regulated (Drife, 2010). Russia was the 
first country to legalize abortion, the law was reversed in 1935, but in 1955 it became legal 
again in most former USSR states. During the second half of the 20th century abortion 
became legal in most Western European countries, but not until the first decade of the 21st 
century was abortion legal in Switzerland, Portugal and Spain (Gissler et al., 2012). Abortion 
was legalized in Japan in 1948 and India in 1971 (Public Health Currents, 1971).  
1.2 MATERNAL MORTALITY 
1.2.1 Measuring maternal mortality 
The WHO defines maternal mortality as death of a woman while pregnant or within 42 days 
of termination of pregnancy, regardless of the duration and site of the pregnancy, from any 
cause related to or aggravated by the pregnancy or its management but not from accidental or 
incidental causes. Pregnancy-related death is a wider definition to facilitate detection of 
maternal deaths, according to this definition all deaths of a woman while pregnant or within 
42 days of termination of pregnancy, irrespective of the cause of death should be included.  
Despite specific goals to reduce maternal mortality set by the global community since 1987, 
there is a lack of reliable measurement tools. Many countries lack reliable data and 
misclassifications and sampling errors are common (Kassebaum et al., 2014). Two sources 
reported a total maternal mortality between 275 300 and 303000 in 2015 (Alkema et al., 
2016; Global Burden of Disease Study Group, 2016) with annual reduction rates of 2,6 and 
1,8% respectively. Global estimates on maternal mortality still lack comparable data to 
evaluate how family planning services, modern contraception and access to safe abortion 
services influences maternal mortality (Global Burden of Disease Study Group, 2016). 
Assessing abortion related maternal mortality is even more complicated and estimates differ 
between studies. Four primary tools are used to estimate abortion related deaths including 
confidential enquiries, vital registration data, verbal autopsy and facility based data. Since  
abortion related maternal mortality is usually reported as a proportion of total maternal 
mortality these numbers say little about weather abortion has become more safe or not 
(Gerdts et al., 2015). and although numbers of annual abortions per 1000 women decreased 
from 40 in 1990 to 35 in 2014, the total numbers of abortion globally increased due to 
population growth (Sedgh et al., 2016). Unsafe abortion is estimated to have caused 7.9% of 
the maternal deaths in 2015 (Alkema et al., 2016). The global burden of disease report of 
23000 maternal deaths attributable to abortion, miscarriage and ectopic pregnancy in 2015, a 
decline by 23% since 2005 (Global Burden of Disease Group, 2016). 
Around 25 per cent of all pregnancies are estimated to have ended in abortion between 2010-
2014(Sedgh et al., 2016). Unintended pregnancies are directly linked to maternal mortality 
and morbidity as they may lead to unsafe abortion with related consequences, and also 
because unintended births have negative impact on the mothers and children’s future socio-
economic status and mental health (Herd et al., 2016). One study using regional estimates and 
survey data reported that 40% of all pregnancies were unintended in 2012(Sedgh et al., 2014). 
Although rates of unintended pregnancies have declined since 2008, nearly half (45%) of all 
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pregnancies were unintended in the US in 2011. Young and poor women were at a higher 
risk. 42% of unintended pregnancies ended in abortion (Finer et al., 2016).  
1.2.2 Abortion and contraception 
Use of contraception is interrelated with abortion and maternal mortality. Yet the unmet need 
for family planning, defined as women who are fecund and sexually active and don’t want 
any more children or to delay the next child, but are not using contraception, is generally 
high. Unmet need describes the gap between women's use of contraception and their 
intentions to reproduce. Fear of side effects, opposition from a partner, or the partner’s fear of 
infidelity, are common reasons for not using contraception. Those reasons are relatively 
similar independent of the setting. The gap between knowledge and uptake of contraception 
leads to a high proportion of women at risk of unplanned pregnancy (Wulifan et al., 2016) 
In 2015 the Global Strategy for Women's, Children's and Adolescents' Health 2016-2030 was 
launched. This strategy aims to end all preventable deaths of women, children and 
adolescents, and to create an environment in which these groups not only survive, but thrive 
(WHO, 2016). The global community also adopted 17 sustainable development goals (SDGs) 
as targets for the global development from 2015 to 2030. SDG 3.1 target for all countries to 
lower the maternal mortality rate (MMR) to 70 by 2030, and SDG 3.7 target the global access 
to sexual and reproductive healthcare. 
The SDGs replace the previous Millennium Development Goals (MDG) of which the fifth 
goal aimed to lower the MMR by 75% from 1990 to 2015. A target for universal access to 
reproductive health care including contraceptive prevalence and family planning services was 
added in 2005.  
The Global Burden of Disease (GBD) was initially commissioned by the World Bank to 
measure disability and death from different causes worldwide. It involves more than 500 
researchers in different disciplines. The GBD considers the prevalence of a disease or risk 
factor and the harm it causes.  Data on maternal mortality is also provided by the WHO, of 
which GBD has been a part, over the years data has differed between the two institutes, 
mainly in data selection, quality appraisal, data processing and adult morality  
1.3 ABORTION 
1.3.1 Medical methods of abortion 
Following the discovery of the highly efficacious abortifacient properties of the combined 
mifepristone-prostaglandin analogue treatment, medical abortion successively became an 
established abortion method. Initially the method was approved in France in 1988 for 
abortions up to 49 days of gestation using an intramuscular preparation of progesterone. 
Gemeprost, a prostaglandin for vaginal administration was developed in collaboration with 
the WHO and approved in the UK in 1991 followed by Sweden in 1992 for abortion up to 63 
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days, and in 1994 for second trimester abortion. Today, misoprostol has replaced gemeprost 
in the recommended regimes. 
A multitude of studies have shown that using the recommended regime of 200 mg 
mifepristone followed by 800 ucg misoprostol vaginally or sublingually after 24 to 48 hours, 
complete abortion is attained in more than 95% of cases (Bettahar et al., 2016). Neither 
ultrasound nor prophylactic antibiotics are needed before treatment, and medical abortion is 
recommended also for use in the case of a pregnancy of unknown location (PUL) provided 
the woman is informed about the risk of ectopic pregnancy (Bizjak et al.).  
Today medical abortion using mifepristone and misoprostol, or misoprostol alone where 
mifepristone is not available, is recommended not only for abortion in the early first trimester, 
but also for abortion in gestational week 9-13 and for termination of pregnancy in the second 
trimester (WHO, 2012a). 
1.3.1.1 Misoprostol globally 
Given the advantages of medical abortion, such as not requiring hospital settings or access to 
anesthesia, it has a huge potential to reduce abortion-related maternal mortality should it be 
approved worldwide. Misoprostol is represented on WHO’s list of essential medicines for 
treatment of induced abortion, incomplete abortion, labor induction, and prevention and 
treatment of post-partum hemorrhage (WHO, 2015b). In addition, it is recommended for 
cervical priming prior to surgical abortion. Misoprostol a synthetic PGE1 analogue, is 
inexpensive and relatively stable at room temperatures, as well as widely available under the 
brand name CytotecÒ for prevention of gastric ulcer. In settings where maternal mortality 
due to unsafe abortion is high, it has been estimated that if 60% of abortions are induced with 
misoprostol, the reduction in mortality would be around 45% (Harper et al., 2007). Today, 
while the approval of mifepristone is limited to 61 countries, misoprostol is approved in most 
middle and high income countries, and also in many countries in sub-Saharan Africa. The 
current status of misoprostol approval and updated clinical guidelines is available at 
http://www.misoprostol.org. 
1.3.1.2 Incomplete abortion and post-abortion care 
Post-abortion care (PAC) is a method to treat complications of unsafe abortions. The model 
includes treatment for incomplete abortion, contraceptive counse 
ling, and management of sexually transmitted diseases when needed (Rasch, 2011). 
Treatment for PAC by midlevel providers is equally effective and safe as treatment by 
physicians in low resource settings (Klingberg-Allvin et al., 2015). High success rates for 
complete abortions are reported using recommended doses of sublingual (400 mcg) or oral 
(600 mcg) misoprostol (Huber et al., 2016). 
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1.3.2 Midlevel providers 
Task shifting and sharing of medical services with trained non-physician providers has 
become an important strategy to ensure medical services where there is shortage of healthcare 
providers and has the potential to increase access to safe abortion. The World Health 
Organization (WHO) has recently developed guidelines recommending that medical abortion 
and treatment for incomplete abortion in the first trimester using clinical interventions that 
have been recommended as safe and effective, can be managed by trained auxiliary nurse 
midwives, nurses, midwives and associate clinicians (WHO, 2015a).  
A government supported program to train non-specialist doctors (MBBS) in India in 
Comprehensive Emergency Obstetric Care (CEmOC) including abortion and post-abortion 
care, following a 16 week course, improved antenatal care in a rural area by 43% (Bhushan et 
al., 2015). 
1.4 BARRIERS TO SAFE ABORTION 
A multitude of barriers influence availability of safe abortion, most interacting with each 
other (Culwell et al., 2013). Some of them are discussed in further detail below. 
 
Figure 1.4 Abortion access: an overview of barriers  
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1.4.1 Legal aspects 
In a global perspective, abortion rates are not significantly different in countries where 
abortion is highly restricted than in those where abortion is broadly legal (Sedgh, Bearak et 
al. 2016). In fact, the lowest abortion rates are seen in some of the countries with the most 
liberal abortion laws. Even in settings where abortion is legal, regulations such as legally 
imposed waiting-times between consultation and treatment, or restrictions on the availability 
or use of misoprostol affects access to abortion. In Alabama the state regulations require in-
person consultation after which women need to wait for 48 hours before treatment. Here, 
many women report not being able to reach an abortion provider in time due to work 
obligations, long travel times and limited opening hours at clinics (White et al., 2016). Legal 
restrictions limiting abortion provision to gynecologists or gynecologists with special 
certifications are common. Restricting off-label use of misoprostol is another way to legally 
restrict access to safe abortion (Dzuba et al., 2013). 
1.4.1.1 Abortion laws globally 
Around one quarter of the worlds’ population live in 66 countries where abortion is either 
prohibited or permitted when needed to save a woman’s life. Fifty-nine countries permit 
abortion to save a woman’s life and health. In these countries abortion is generally permitted 
on therapeutic grounds in, this is the level of access for 13.8% of the world’s population. In 
thirteen countries, including Great Britain, Belize and Zambia, abortion is permitted for 
socioeconomic reasons and the laws are generally liberal. These countries are home to 21.3% 
of the world’s population. There are 61 countries, home to 39.5% of the global population, 
where abortion laws are liberal, most of those apply a gestational limit for abortion. Figure 
1.4.1. 
 
Figure 1.4.1 The global populations’ access to abortion. Population in 199 countries grouped 
per legal status, 199 countries 2014. Adapted from Center for Reproductive Rights. 
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The Center for reproductive rights provide an interactive and updated map of the world’s 
abortion laws at http://worldabortionlaws.com. 
1.4.2 Administrative barriers 
Even in settings where abortion is legal there may be administrative barriers obstructing and 
delaying access to abortion. Such barriers can include obligatory counseling aiming at 
persuading the woman to keep the pregnancy, requirements for two-doctors signatures to 
approve the indication for abortion, requirements to limit facilities approved to do abortions, 
regulations on clinical use of misoprostol, obligatory in clinic follow-up, requests on waiting 
times between consultation and decision about abortion, requests for partner or parental 
consent, administrative fees, and augmented prices on medication (Hirve, 2004). 
1.4.3 Infrastructure 
Infrastructure has impact on health care availability in all types of settings. It includes a 
variety of factors such as availability of health care facilities and women’s access to 
transportation (Margo et al., 2016). Even in settings where there are hospitals and clinics, 
women are not guaranteed treatment. For instance, it is becoming increasingly common that 
hospitals in the United States don’t provide abortions. It is reported that more than one out of 
nine hospitals in the United States claim religious affiliation. Other reasons for hospitals not 
to perform abortions include marketing reasons, and wanting to avoid negative press that 
might ultimately impinge hospital finances (Eisenberg et al., 2016). 
1.4.4 Costs 
The cost of providing or obtaining an abortion has the potential to limit availability of 
abortion care services, as well as women’s possibility to access abortion care.  
A study conducted at public hospitals in South Africa reports that women seeking care for 
second trimester abortion lost income and had to pay for transportation, sanitary pads and 
doctors’ fees. A way to minimize those costs was to simplify the procedure by reducing 
numbers of visits to the hospital. Other measures to reduce women’s out of pocket expense 
include provision of sanitation products and pregnancy tests for free (Lince-Deroche et al., 
2015). A study from Zambia, that has a permitting legal framework for abortion, states that 
around 70% of abortions were unsafe in 2009. Numbers of doctors are low, especially in rural 
areas, and women lack knowledge about the legal status of abortion and how to access 
abortion services. In addition to putting themselves at risk while seeking treatment for unsafe 
abortions, the women paid up to 70% more than had they sought care at a government 
hospital (Leone et al., 2016). Another study from the same setting concluded that many 
women opted to seek an unsafe abortion in order to avoid disclosure(Coast et al., 2016). 
 
It is difficult to generalize about health system and hospital costs for abortion and treatment 
for incomplete abortion due to great variation in organization of health facilities, methods, 
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and settings. A systematic review with data from 1985 to 2007 estimated that hospital and 
health system costs for post abortion care, using surgical or medical methods, per case was 
US$392 in Africa and US$430 in Latin America respectively (2007 US$)(Shearer et al., 
2010) 
1.4.5 Women 
Women both in high and low resource settings experience barriers to abortion. Barriers are 
interlinked with previous themes and include administrative barriers such as difficulties in 
obtaining appointments and delayed or non-referral, transportation difficulties especially in 
rural areas as well as stigma (Heller et al., 2016). Lack of knowledge about sexual and 
reproductive health including abortion and contraception, legal rights and where to seek 
treatment for safe abortion influence women’s abortion-seeking behavior. Acceptability of 
the provider, including perceived quality of services, and feeling treated with respect and in 
confidentiality are other factors that influence abortion seeking behavior (Culwell et al., 
2013). 
1.4.6 Stigma 
Abortion is highly affected by stigma which has consequences both women, their care-
seeking behavior, and providers’ willingness to perform abortions. Stigma is a social 
phenomenon that stems from perceived human differences, and from over simplifying 
complex situations.  Studies from different settings confirm that women are subject to social- 
and self-judgement and experience a need for secrecy during and after the abortion process 
(Hanschmidt et al., 2016). One reason for stigma being so strongly associated with abortion 
may be that abortion challenges womanhood. A cycle of silence stands model for production 
and fueling of abortion stigma. It builds on the perception that abortion is uncommon, which 
in turn leads to women under-reporting abortions which in turn reinforces discrimination and 
fear (Kumar, Hessini et al. 2009).  Figure 1.4.5 
Stigma is also a reflection of social inequalities and more apparent in societies where 
women’s status is low. 
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Figure 1.4.4 The cycle of silence: the social construction of deviance despite high incidence 
of abortion, adapted from (Kumar et al., 2009). 
Abortion providers are subject to stigma on a more daily basis than abortion-seeking 
women. It may include repercussions from colleagues as well as harassments and fear of 
disclosing one’s work in social settings leading to stress and professional difficulties 
(Norris et al., 2011).  
1.4.7 Providers   
Availability of abortion providers is limited in many regions. In developed countries many 
potential abortion providers are unwilling to provide services. This may be due to lack of 
training and negative attitudes, but also because of perceived threats to themselves or their 
families (Doran et al., 2015). In low-resource settings there is a ubiquitous scarcity of health-
care providers. Although potential providers are sympathetic with abortion seeking women, 
and aware of the positive impact safe abortion services have on women’s lives and overall 
maternal mortality, many are reluctant or unwilling to provide abortions claiming moral or 
religious reasons, or negative attitudes at the workplace (Harries et al., 2009). Training and 
practice in comprehensive abortion care has been shown to influence provider attitudes and 
increase the likelihood that they will include abortion and PAC in their practice (Wheeler et 
al., 2012). 
1.4.7.1 Conscientious objection 
Claiming conscientious objection (CO), refusal to provide services included in your 
profession, is becoming increasingly common. Estimates from the UK state that 10% of 
obstetrician-gynecologists claim conscientious objection while refusing to provide abortions. 
In Italy the corresponding number is 70% (Chavkin et al., 2013). Such actions stigmatize 
women, especially those living in precarious circumstances and in settings where abortion 
rights already are limited, and reduces access to health care services, thus aggravating 
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inequities in health systems. Conscientious objection also impairs access to abortion and thus 
contributes to morbidity and mortality from unsafe abortion (Kassebaum et al., 2014). 
Countries that don’t permit CO, including Sweden, Finland and Iceland have high levels of 
gender-equality and religious influence is limited. Although birthrates are slightly higher than 
in other western European countries, teenage birthrates are low. Advantages for a society that 
doesn’t allow CO includes that women are guaranteed that all obstetrician-gynecologists will 
perform abortion within the limits of the law, and that clinicians are guaranteed that 
professional duties are shared equally (Fiala et al., 2016). 
1.5 INDIA 
1.5.1 Maternal mortality 
The MMP in India was reported to be 178 maternal deaths (per 100 000 live births) in 2012. 
This corresponds to 19% of the global maternal mortality (Joe W, 2015). Data from 2003 
suggests 8% of the maternal deaths are caused by abortion (RGI Registrar General India, 
2006). 
1.5.2 Sex selection 
The gender imbalance among newborns in India continued to increase from 2011-2012 to 
2012-2013 reports the civil registration system of India. Sex selective abortion is an 
increasing problem in South East Asia since pre-natal sex-determination through ultrasound 
and blood testing became available. Factors associated with son-preference is patrilinear 
inheritance, farm-dependent economies and the dowry system practiced in many countries in 
the region. In order to limit the practice of sex selective abortions societies have taken 
measures such as banning pre-natal ultrasounds to determine the sex of the fetus (Ganatra, 
2008). Such moves have not been successful, instead they have led to impairment of access to 
safe abortion for other reasons. 
Official statistics for India reported a sex-ratio of 909 in 2011 and 898 in 2013. It is estimated 
that 85.6% of all births were reported in 2013 (Registrar General and Census Commissioner 
India, 2015). The global sex-ratio among infants is reported to be 1.13% (90%CI 1.12 to 
1.15%)(Alkema et al., 2014). 
1.5.3 Legal regulation of abortion 
Abortion became legal in 1971 under the Medical Termination of Pregnancy (MTP) act. It 
permits abortion provided by a registered medical practitioner up to 12 weeks of gestation, 
and after recommendation from a second registered practitioner up to 20 weeks. The 
conditions are that continuing the pregnancy would involve a risk to the life of the pregnant 
woman, or to her physical or mental health; or that there is a substantial risk that the child 
would suffer from physical or mental abnormalities leading to a serious handicap 
(Government of India, 1971). The law was amended in 2002 to permit medical abortion.   
The pre-conception pre-natal diagnostic techniques act (PC-PNDT) regulates the use of 
diagnostic techniques to determine the sex of the fetus. In order to increase access to safe 
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reproductive health care there is an ongoing process to further amend the regulation of 
abortion to allow non-physician providers to perform abortions (MoHFW, 2014). 
1.5.4 Medical education in India 
Medical education in India is rigorously regulated by the Medical Council of India with 
several amendments, mostly regarding admission criteria (Medical Council of India, 1997). 
Selection of students is based on merit and requires a qualifying examination. The qualifying 
exam is usually the Higher Secondary Examination or the Indian School Certificate which 
includes science subjects, mathematics and English. Both national and institutional goals 
govern undergraduate medical education.  
The theoretical education is 4,5 years. Phase I (2 semesters) consist of pre-clinical subjects, 
phase II (3 semesters) of para-clinical and clinical subjects, and during phase III clinical 
subjects (medicine, surgery, gynecology and obstetrics and community medicine) are taught. 
It is stipulated that maximum one third of the tuition time should consist of regular lectures, 
and the remaining two thirds should include practical and clinical sessions as well as group 
discussions. The council suggests that clinical postings of three hours daily take place from 
semester three through semester nine. 
The tuition in Obstetrics and Gynecology, which includes maternity training, family planning 
and family welfare planning, adds up to a total of twenty-four weeks after which the student 
shall have acquired knowledge including understanding of contraception, methods of medical 
termination of pregnancy, sterilization and its complications, and skills in pelvic examination. 
The student should also have assisted in insertion and removal of intrauterine devices. 
Attendance levels of 80% are required in the non-lecture teaching including hospital postings 
and bed-side clinics.  
After the final theoretical examination, the medical students are required to participate in a 
rotational internship for one year during which the student is supposed to practice medicine 
and health care under supervision. The internship should take place at different levels of the 
health system from primary health centers to teaching hospitals. During internship the student 
should acquire experiences corresponding to two months of clinical practice in Obstetrics and 
Gynecology and Family Welfare Planning. The curriculum in Obstetrics and Gynecology 
includes knowledge about reversible and irreversible contraceptive methods ranging from 
“rhythm methods” through condoms, contraceptive pills, intrauterine devices to tubal ligation 
and vasectomy. The curricula should also include contra-indications to contraceptives and 
“toxic” effects of contraceptives. Training is assessed by a record of work and “situation 
tests” of knowledge, skills and attitudes. The Dean or Principal of the college issues a 
certificate of satisfactory completion, and the university grants the student the MBBS degree.  
Internship has been criticized for not providing enough skills. A majority of medical students 
aim to seek post graduate education and many students use the time during internship to 
study for the entrance exam (Bansal, 2004; Chaturvedi et al., 2001). A more recent study 
shows that medical students knowledge in clinical pharmacology with emphasis on treatment 
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of tuberculosis and malaria decreased from phase II/III in medical education to internship and 
concludes that classroom teaching is insufficient and clinical teaching needs to be reinforced 
(Desai et al., 2016). 
1.6 ACCESS TO SAFE ABORTION A CONCEPTUAL FRAMEWORK 
The overall aim of this thesis is to explore factors that influence access to comprehensive 
abortion care focusing on provider availability in different settings.  
A common definition of access is the freedom or ability to obtain or make use of something 
(Marriam-Webster). How to define and improve access to health care has eluded scientists 
since the mid-20th century. 
A conceptual framework is defined as a model to organize and describe research evidence, 
design, and methods that explains what is to be studied (key factors, concepts, or variables) 
and their interrelation (Maxwell, 2013). Different models, or conceptual frameworks have 
been developed to describe health care access. The basis for most models of access to health 
care are a supply side, availability of services, and a demand side, utilization of services. A 
multitude of factors have been added to emerging models, usually increasing complexity.  
Factors that may facilitate or impede the uptake of services are for instance geographical, 
organizational and financial but also personal, social and cultural influences. Other factors 
that are  considered to influence access to healthcare are the  appropriateness of services, and 
the services effectiveness at achieving desired health outcomes (Gulliford et al., 2002).  
The behavioral, or utilization, model of access, was first presented by Anderson et al in 1968 
to predict and explain use of health services. In this model, which has been extensively used, 
utilization of healthcare is determined by population characteristics on one side described as 
predisposing, enabling and need components. On the other side are health system 
characteristics: resources and organization. The concept of “the system” which includes 
health care policy in addition to resources and organization was introduced in the second 
version of this model. This version describes how the outcomes “utilization of health care” 
and “satisfaction with health care services” evolves from the objectives of the health policy 
through the characteristics of the health care system (resources and organization) and the 
populations’ predisposing characteristics (gender, age, values), enabling characteristics 
(financial and regional means to use the services) and their  need for healthcare (Aday et al., 
1974). Figure 1.6.1 
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Figure 1.6.1. Framework for study of access, adapted from Aday & Andersen 1974 
The later versions of the behavioral model are multilevel models that incorporate both 
individual and contextual determinants of health services use. They build on the three major 
components, predisposing factors, enabling factors and need factors, identified in the original 
model. A systematic review of the use of the behavioral model showed that the model’s 
complexity had not been adequately operationalized, and that statistical methods, such as 
testing of multivariate models, was not employed. Therefore, the explanatory power of the 
results is restricted and is often limited to single indicators (Babitsch et al., 2012).  
Pechansky and Thomas aimed to operationalize the concept of access, which they defined as 
the “degree of fit” between patients and health-care services. They identified five areas of 
“fit” between the health care system and the patient: availability, accessibility, 
accommodation, affordability and acceptability. These areas are related to, but not identical 
with, the enabling variables described by Andersen et al (predisposing factors, enabling 
factors and need) (Penchansky et al., 1981). 
Access to health care is defined as the empowerment of an individual to use health care by 
McIntyre and coworkers (McIntyre et al., 2009). This model reflects the individual’s capacity 
to benefit from services given the individual’s circumstances and experiences in relation to 
the health care system. Access is described as a three-dimensional concept where availability, 
affordability and acceptability interact. According to this theory, decision-makers need both 
to make health care services available and to empower individuals to use health care services 
when needed. Differences in use of healthcare depends on empowerment and individual’s 
choices.  
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The three dimension of access are defined as:  
• Availability: are the right health care providers available in the right place and at the 
right time? And are providers able and willing to serve the patients at the facility. 
• Affordability: the full cost to the patient and his/her ability to pay. This includes direct 
costs but also indirect costs such as travel and waiting times. 
• Acceptability: refers to provider and patient attitudes and expectations towards each-
other. Acceptability is also influenced by beliefs and perceptions, factors that may 
lead patients to self-care or traditional healing.  
In this model, access is influenced by unequal power relations that impair provider-patient 
communication. Those relations are in turn affected by medical training. The authors 
summarize their conceptualization as “the right health service being available in the right 
place at the right time”. 
Levesque and coworkers have synthesized the most cited frameworks of access to further 
develop and define access as “the opportunity to reach and obtain appropriate health care 
services in situations of perceived need for care”(Levesque et al., 2013). Access occurs in 
the process between the demand side (persons, households, social and physical 
environment) and the supply side (health systems, organizations and providers). Process 
factors, that describe how access is realized, are also considered.  
Accessibility is described as five-dimensional (affordability, acceptability, availability and 
accommodation, affordability and appropriateness).  Here, acceptability relates to cultural 
and social factors that determine peoples’ acceptability of the provided services and their 
 
 
Figure 1.6.3 Access framework, adapted from Levesque et al 2013. 
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Gilson discusses the importance of acceptability and trust to diminish the socio-cultural 
distance between health-care systems and the individuals (Gilson, 2007). The concept of 
equity is introduced and discussed in terms of systematic differences in the experience of 
health care between population groups. Three elements of acceptability are identified: 
• The fit between health beliefs held by individuals and health-care providers. This fit 
influences care seeking behaviour and  depends on lay beliefs about health and 
healing and the percieved competence of providers.  
• The engagement and dialogue between patient and provider which is a function of 
power and trust. 
• The organization of provided health-care which can enable or disable the patient’s 
access to health services. 
In this thesis, access to comprehensive abortion care is explored from the supply side aspects 
of provider’s attitudes and willingness to provide services and the cost-effectiveness of task 
shifting provision of medical abortion from physicians to nurse-midwives, and the demand 
side aspect of acceptability of services.  
1.7 THE FUTURE 
Despite years of scientific progress unsafe abortion is still the cause of substantial maternal 
mortality. Modern abortion methods are effective and safe, but women don’t get access to 
treatment when needed. During recent decades the scientific community and activists have 
developed new methods for distribution of medical abortion aiming to bridge the access gap. 
Simplified medical abortion, or home use and self-assessment of abortion outcome, is 
available from clinics in an increasing number of countries. Most often such regimes include 
an initial visit to a clinic to assess eligibility and gestational age. Abortion is then initiated 
with 200 mg oral mifepristone and women continue the treatment using oral or vaginal 
misoprostol at home. Simplified treatment is equally effective and acceptable as clinic use 
(Iyengar et al., 2016; Kopp Kallner et al., 2012; Oppegaard et al., 2015). 
For women in settings where abortion is restricted the internet has opened new possibilities. 
Organizations such as women on web provide home-treatment for medical abortion using 
self-assessment of eligibility. Internet-based home abortion is effective safe and acceptable to 
a majority of women (Aiken et al., 2016; Gomperts et al., 2008). Internet self-assessment 
tools are also used in settings where abortion is legal but where access is limited due to other 
reasons such as long travel times. (Momberg et al., 2016). 
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2 AIMS 
The overall aim of this thesis is to study factors that influence access to comprehensive 
abortion care focusing on increasing provider availability in different settings. 
 
The specific aims of the studies are:  
Study I:  
To explore attitudes toward abortion held by medical interns in the state of Maharastra, India, 
and also to determine whether those attitudes differed between groups of interns defined by 
sociodemographic backgrounds and study program characteristics. 
Study II: 
To explore the attitudes and perceptions toward abortion care services, medical abortion and 
task shifting in abortion care among medical students in their internship year, in Maharastra, 
India. 
 
Study III: 
To conduct a cost-effectiveness analysis of medical abortion provided by nurse-midwifes or 
physicians in a high resource setting. 
 
Study IV: 
To review the efficacy, safety, and acceptability of non-physician provision of first trimester 
medical abortion including medical treatment for incomplete abortion. 
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3 MATERIAL AND METHODS 
The studies included in this thesis cover different factors influencing access to and provision 
of abortion care, and medical abortion in particular in different settings. Quantitative and 
qualitative methodologies were used to cover different perspectives on abortion access and to 
obtain an overview, as well as in depth knowledge. A summary of included studies is 
provided below in Table 3.1. 
Study  Location Time of data 
collection 
Design and 
method 
Type and number of 
participants 
I. Medical Student's attitudes and 
Perceptions on Abortion:  a cross-
sectional survey among medical 
interns in Maharastra, India 
27 medical 
colleges  
February 2011 Cross-sectional 
survey 
Medical Interns (5th 
year of study)  n= 1 
996 
II. Medical students are afraid to 
include abortion in their future 
practices: in-depth interviews in 
Maharastra, India 
6 medical 
colleges  
December 2012 
to April 2013 
Inductive 
approach using 
In-depth 
interviews. 
Thematic 
analysis 
Medical Interns (5th 
year of study) n=53 
III. Medical abortion provided by 
nurse-midwifes or physicians in a high 
resource setting: a cost-effectiveness 
analysis 
Outpatient clinic 
at University 
hospital in 
Stockholm 
Sweden 
Feb 2011 to July 
2012 
Cost 
effectiveness 
analysis 
alongside a  
randomized 
controlled 
equivalence 
study 
Healthy women 
seeking treatment for 
medical abortion 
(n=1180). Nurse-
midwives (n=2), 
physicians (n=34) 
IV. Effectiveness, safety and 
acceptability of non-physician 
provision of first-trimester medical 
abortion: a systematic review 
Worldwide Inception to 
April 2016 
Systematic 
review 
Electronic databases  
were searched using 
selected search terms 
for provider types 
and medical abortion 
Table 3.1 Overview of included studies 
3.1 STUDY I AND STUDY II 
Study I and II aimed to explore attitudes and perceptions toward abortion and contraception 
among medical students and were conducted in Maharastra, India.  
3.1.1 Research process 
The first two studies were conducted among medical students in Maharastra, India using a 
quantitative and qualitative approach. Study I was a cross-sectional survey conducted among 
undertaken before a workshop in comprehensive abortion care held by a local NGO. We 
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found that misconceptions about the law were common, one quarter of the respondents 
considered abortion to be morally wrong and one fifth stated that abortion should not be 
accepted for unmarried women. These findings informed the second study that aimed to 
further explore the findings about poor attitudes toward abortion. The studies were conducted 
in the same setting, which is introduced below.  The first study was initiated as a project 
conducted by a Swedish medical student in his last year during a student-exchange with the 
local NGO. I became involved after the data collection, went through all the collected 
questionnaires, cleaned the data-base and performed all subsequent analysis together with the 
co-authors.  
As Indian medical education has a focus on family-planning the results rose a lot of 
questions, and we decided to explore the subject further through in-depth interviews in the 
same population, medical students in their last year in Maharastra, India. 
The interviews were conducted in English by me, a Swedish-Obstetrician Gynecologist. At 
the time of the studies I had been living in India for one year (Study I) and two and a half 
years (Study II). After three years in India I had become somewhat familiar of Indian culture.  
I had become accustomed to the local use of English, “Hinglish”, and I had acquired some 
understanding of basic Hindi.  
Although the tuition language at all the colleges was English, the spoken languages among 
students as well as teachers was either “Hinglish”, a denomination that describes a mixture of 
languages combining English and Hindi, or local languages such as Maharati. Hinglish is 
described as an informal language of the Indian middle class and the aspirational language of 
the upwardly-mobile classes (Orsini 2015). As I had previously noticed when communicating 
in various Indian settings, students tended to use complicated English words, that I am unsure 
they understood, in cover lack of understanding and/ or knowledge of the question or topic. 
Thus paraphrasing and explanation of the topic was often needed during interviews to ensure 
the respondents understanding of the question, as well as repetition and rephrasing of his or 
her answers to ensure that my understanding was correct. My relatively long experience as a 
westerner in India supported my understanding of the meaning of what was being said. 
India is a country of authority and being older and, as an Obstetrician-Gynecologist, in a 
superior position within the medical system, I took great care to establish trust and an open 
dialogue to minimize the risk that students may become intimidated and/ or refrain from 
expressing their true views due to respect. I had specifically requested to be able to conduct 
interviews in a private environment, but I believe the common understanding of privacy is 
different in a populous country such as India compared to my Scandinavian background. I 
was always allocated a room in which to conduct the interviews, but we were often 
interrupted by people coming into the room for different reasons. 
3.1.2 Setting 
India is a country with a vast rural population experiencing limited access to safe abortion 
services. Unsafe abortion is estimated to cause 8 % of maternal mortality despite decades of 
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legal abortion (Joe W, 2015). There is a lack of registered facilities and providers in rural 
areas, and implementation of medical abortion has been slow due to lack of medicines and 
low awareness among physicians (Creanga, Roy et al. 2008, Acharya and Kalyanwala 2012). 
Maharashtra is India’s second largest state by population, and the third largest by area. It had 
112 million inhabitants at the time of the survey figure 3.1.2. Mumbai is the state capital and 
the largest city in India with around 13.3 million inhabitants, but a more than half of the 
state’s population live in rural areas. In 2010-2012 the Maternal Mortality Rate (MMR) in 
Maharastra was 87 (95%CI 52,138) which was around half of the average in India of 178 
(Joe W, 2015). A more recent report from verbal autopsies in 31 purposive sampled of 10 
states in India find that around 4% of maternal deaths are due to complications of abortion 
(Subha Sri B, 2014). Male and female literacy was 90% (82%) and 75% (65%) respectively 
(national average). The 2011 census found child sex ratio (0-6 years) to be 883 females per 
1000 males, compared to the national average of 914, and this gender gap increased in the 
decade 2001-2011 (Government of India, 2011 #57). The state of Maharastra has actively 
implemented the PC-PNDT act and had, until 2013, cancelled the highest number of medical 
practitioner licenses, 37, for violation of the law in India.  
The medical council of India regulates medical education, and it is conducted at either public 
or private colleges. The medical education curriculum is national and stipulates that the 
theoretical part of the studies should cover Comprehensive Abortion Care (CAC),  
contraception and counseling (Supe et al., 2006). At the time of the studies there were 5945 
medical students in Maharastra attending 44 medical colleges offering the MBBS degree. 
Nineteen of the colleges were run by the government (India). 
 
Figure 3.1.2 Map of Maharastra, adapted from www.mapsopensource.com 
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3.1.3 Study I  
3.1.3.1 Instrument 
A structured questionnaire was developed to measure medical students attitudes towards 
contraception and abortion based on a previously tested instrument Klingberg-Allvin et al. 
(2007). The questionnaire consisted of three sections covering sociodemographic background 
(5 questions), educational background including the respondent’s assessment of their own 
knowledge and training in the field of sexual and reproductive health (7 questions), and 
attitude statements on abortion and contraception (15 and 13 statements respectively) 
(Appendix A). Responses were marked on a five-point Likert scale (Spector, 2004). 
Positively and negatively worded statements were included to reduce bias. One question in 
the training section “What do you think are the special problems within sexual and 
reproductive health today in India” was open-ended and not included in the analysis. The 
survey-development and data collection was undertaken as a medical student degree project 
by the third author and took place before I got involved in the project. Results regarding 
contraception are presented in another paper (Hogmark et al., 2013).  
3.1.3.2 Study population and sampling 
Medical students in their fifth and final year of education (internship) were eligible for 
participation in the studies. Study I was conducted in February 2011 at 27 colleges, of which 
eight were government and 19 were private, where a CAC workshop covering aspects of 
abortion care included in the curricula of medical education was conducted. The included 
colleges were a convenience sample from 43 medical colleges in the state of Maharastra at 
the time of the study and in total 2006 students participated. 
The three hour CAC orientation workshop was held by a non-government organization 
partnering with the government. The objective of the workshop was to impart correct 
knowledge on various aspects of abortion care including the magnitude of unsafe abortions, 
the legal aspects of abortion care according to the Medical Termination of Pregnancy Act, 
abortion techniques and post-abortion contraception included in the curricula of medical 
education (Government of India, 1971; Ipas). Out of 2006 eligible medical students 1996 
participated.  
3.1.3.3 Analysis 
All questionnaires with at least one answer were included in the data-analysis. Ten 
questionnaires were blank and therefore excluded. Descriptive statistics were applied to 
determine frequencies and proportions, any difference with a 95% confidence interval (CI) 
was regarded as significant. The alternatives disagree completely and disagree as well as 
agree and agree completely, were aggregated to calculate proportions and frequencies. 
Intergroup differences for gender, type of college and place of birth, as well as for how 
students assessed their education in and knowledge of sexual and reproductive health, was 
analyzed and cross-tabulations were made. Statistical Package for Social Studies (SPSS) 21 
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software was used.  
3.1.4 Study II 
3.1.4.1 Topic guide 
To further explore and complement the findings from Study I we conducted a qualitative 
study using in-depth interviews. A topic guide to explore students’ attitudes and perceptions 
toward comprehensive abortion care was developed using with open-ended questions and 
probes. An emergent approach was employed and the  interview guide was constantly revised 
as information from one interviewee influenced the interviewer’s knowledge of the subject 
(Kvale et al., 2009). 
3.1.4.2 Study population and sampling 
Study II was conducted at between December 2012 and April 2013. Purposive sampling of 
six colleges among the 28 colleges that had previously participated in Study I took place. 
Eligible students were sought out by a key-informant, usually the head of the department at 
each college. Sampling of students aimed to create maximum-variation in representation with 
regards to socio-geographical-cultural backgrounds. Interviews were conducted with 23 
medical students until theoretical saturation was reached. The interviews lasted between 30 
min to one hour. All interviews were tape-recorded and field notes were taken. 
3.1.4.3 Analysis 
The interviews were transcribed verbatim. Between interviews initial analysis and further 
development of interview guides and probes was conducted. Thematic analysis with an 
inductive approach was used to evaluate data. This approach provides a qualitative, detailed 
account of the data that includes a systematic element characteristic but also permits the 
researcher to combine analysis of their meaning with their particular context (Vaismoradi et 
al., 2013). All transcribed material was read through several times, and I listened to the tapes 
for clarification which also took me back to the interview setting and added to contextual 
immersion. During this process I also went back to my field notes and research diary to 
further re-familiarize with the data. In the process of identifying meaning units I considered 
manifest (what the text says) and latent (underlying) ideas and assumptions. Data was coded 
and organized into units of analysis to identify patterns, subthemes and themes that were 
reviewed and refined until no new information was added (Braun et al., 2006). Meaning 
units, patterns and themes were discussed and agreed upon within the research team.  
To ensure anonymity of the respondents, the informants identification numbers were re-coded 
so that the number presented alongside the quotes in the paper doesn’t correspond to the 
chronological order of the interviews. 
Although the interviews were conducted at colleges where English was the official tuition 
language, and quotes generally are reported verbatim in qualitative papers, some of the 
presented quotes were edited to assure readability and ensure the reader’s understanding of 
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the meaning of what was said. The editing included conversion of spelling to standard 
English, and in certain cases changes of wording and grammar. During this process 
discussions with co-authors took place so that the transcripts represents the true meaning or 
veracity. Common transcription conversions such as [ ] to indicate material added by the 
author, and … to indicate material omitted by the author (Green 2009). 
3.2 STUDY III 
The third study was a cost-effectiveness analysis comparing provision of early medical 
abortion by nurse-midwives or physicians. It has previously been shown that non-physicians 
provide medical abortion as effectively and safely as physicians in a different setting, but the 
cost-effectiveness of such task shifting remains to be established. The study was conducted 
alongside a previously published randomized controlled equivalence study from a university 
hospital in Stockholm, Sweden (Kopp Kallner et al., 2014).  
3.2.1 Efficacy measures 
In the RCT, 1180 healthy women seeking treatment for abortion at an outpatient clinic 
between February 2011 and July 2012 were randomized to treatment by a nurse-midwife 
(n=597) or a physician (n=583). The intervention was treatment by nurse-midwives who 
counseled, examined and performed dating by vaginal ultrasound, and treated the women 
independently. The standard treatment consisted of counseling and physical examination 
including ultrasound by a physician, additional information and medication was given by a 
nurse-midwife. The allocated care-giver provided contraceptive counseling and prescription. 
The treatment regime was mifepristone 200mg orally at the clinic on the first day, one to two 
days afterwards 800 mcg misoprostol was given vaginally, at home or in the clinic. Follow-
up took place approximately three weeks after the mifepristone administration using a low 
sensitivity urinary human chorionic gonadotropin (u-hCG) test. Efficacy was defined as 
complete abortion without need for surgical intervention. Safety, complications and women’s 
acceptability of the procedure were also assessed. The duration of the patients’ visit to the 
clinic, and the allocated provider’s need for a second opinion from a doctor, was recorded. 
3.2.2  Cost calculations 
Direct costs were calculated for the woman’s first visit to the clinic according to allocation. 
Indirect costs evaluated were the costs of the next patient’s reduced waiting time and the cost 
of complications. The treatment on day two (24–48 hours after mifepristone) and follow-up 
did not differ between groups and were not included as costs were the same between groups. 
Cost for salaries and examination rooms were obtained from Karolinska University Hospital, 
Stockholm, Sweden in 2011. The costs were dependent on treatment time which was mean 
60 minutes in the physician group, and 42 minutes in the nurse-midwife group (P<0.001). 
Consultation costs was calculated using the average consultation time and the average salary 
of participating physicians. Costs of time of the treated women and the next patients’ reduced 
waiting time was estimated from the average income among women in the corresponding 
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age-group in Stockholm county. Training costs for the nurse-midwifes were calculated using 
the cost of an ultrasound course for midwifes providing medical abortion and included the 
salary costs of the participating midwifes and supervising doctors. The reimbursement 
according to the diagnostic related group system (DRG) was used estimate the cost of 
complications. There was no difference in costs of disposables, ultrasound, or medication. 
Cost were calculated per procedure in Swedish Krona (SEK) and converted to 2011 Euro 
(EUR) (average exchange rate 2011; 1 Euro € = SEK 9.0298). 
3.2.3 Cost-effectiveness analysis 
Cost-effectiveness analysis (CEA) is an economic evaluation where costs and consequences 
of a health program or treatment are examined.  
To compare the cost for a complete abortion without surgical intervention we calculated the 
incremental cost effectiveness ratio (ICER) for the intervention and standard treatment. The 
ICER considers changes in effectiveness as well as cost of treatment and is established using 
the formula: [𝐂𝐨𝐬𝐭	𝐨𝐟	𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧– 	𝐂𝐨𝐬𝐭		𝐨𝐟	𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝	𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭][𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬	𝐨𝐟	𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧– 	𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬	𝐨𝐟	𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝	𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭] 
We calculated the ICER for different cost measures: direct costs, direct costs including 
reduced waiting time, and total indirect and direct costs. The risk difference, stating that 1,6 
fewer women needed surgical interventions per 100 treated women in the nurse midwife 
group, was the effectiveness measure.  
The cost-effectiveness plane is a tool to illustrate ICER. It was initially developed by (Black, 
1990) to illustrate cost-effectiveness and its’ relevance to medical decision-making. The 
horizontal axis represents the difference in effect, or impact of the intervention on health 
outcomes and the vertical axis depicts net costs (Santerre RE, 2007). The origin (0) represents 
the standard treatment and slope of the diagonal line represents the maximum acceptable cost 
effectiveness ratio (Drummond MF, 2005). The first quadrant represents a situation where the 
intervention is more expensive and less effective than the intervention treatment, the 
intervention is then said to be dominant. Quadrant two depicts the situation where the 
intervention is more expensive and more effective than the standard treatment. Whether the 
new treatment is worth adopting depends on how much money one is willing to pay for the 
improved health. The third quadrant shows the opposite case: the intervention is less costly 
but also less effective. In this case it is important to establish whether the savings are worth 
the decrease in health. Until today the major emphasis in healthcare has been improving 
health and extending life, thus this alternative has been paid little attention in the literature. 
The fourth quadrant illustrates a situation where the intervention is cheaper and more 
effective, thus the ICER becomes negative (Figure 3.2.3) 
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 D cost (CI-CS) 
             D effectiveness (EI –ES) 
Figure 3.2.3 The cost effectiveness plane adapted from (Black, 1990) 
3.3 STUDY IV 
The fourth study was conducted to review the effectiveness, safety and acceptability of non-
physician provision of first trimester medical abortion and medical treatment for incomplete 
abortion. This review was initiated as part of the evidence syntheses for the WHO guideline 
on health worker roles in safe abortion care and post-abortion contraception, that considered 
different cadres of non-physician providers separately (WHO, 2015a). 
The systematic review was conducted according to WHO’s principles for guideline 
development while following PRISMA guidelines (Moher et al., 2009; WHO, 2012b).  
Previously published systematic reviews on midlevel provision of abortion neither include 
medical treatment of incomplete abortion or assess acceptability (Barnard et al., 2015; Ngo et 
al., 2013; Renner et al., 2013). 
3.3.1 Inclusion criteria  
PICOs (participants, interventions, comparisons, outcomes and study designs) were defined 
by WHO at scooping meetings in 2011, where experts from all regions attended. The PICO’s 
were finalized by the WHO steering group and by the WHO guideline development group in 
2014. 
• Participants were pregnant women seeking medical abortion up to 12 weeks of 
gestation, or medical treatment of incomplete abortion. 
II: Intervention 
treatment more 
costly and more 
effective  
III: Intervention 
treatment less 
costly, less 
effective 
I: Intervention treatment 
more costly but less 
effective 
 
IV: Intervention 
treatment more 
effective and 
less costly 
0 
A 
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• Intervention was medical abortion or medical treatment of incomplete abortion 
provided by non-physician providers  
• Comparisons were medical abortion or treatment of incomplete abortion provided by 
physician.  
• Outcomes were effectiveness, safety and acceptability.  
• Study designs were randomized controlled trials (RCTs), equivalence and non-
inferiority trials, and comparative observational studies including cohort and case-
control studies  
3.3.2 Search strategy and data collection 
Medical subject headings (MeSH) and free text words (tw) were used to develop search 
strategies for the databases PubMed, EMBASE, CINAHL, POPLINE, Global Index Medicus, 
Cochrane database, and ClinicalTrials.gov. Searches were conducted in July 2014 and 
completed in April 2016  
We initially reviewed titles and abstracts, and if needed the full article. Additional 
information was collected from reference lists and other reviews. Researchers in the field 
were contacted.  
3.3.3 Data analysis 
The findings were summarized using standardized abstraction forms to identify PICOs. Risk 
of bias assessment was also systemized in standardized forms.  
3.3.4 Quality of evidence  
Meta-analyses were conducted using The RevMan 5.3 software (Collaboration Cochrane, 
2014). The GRADE system was used to assess the quality of evidence(GRADEpro, 2015). 
3.4 ETHICAL CONSIDERATIONS 
All studies were conducted in accordance with the World Medical Association Declaration of 
Helsinki (World Medical, 2013). 
Study I: The principal at each college gave permission to conduct the study in connection to 
the workshop. Before questionnaires were handed out, oral information about the study was 
given to all eligible participants, and it was explained that participation was anonymous and 
voluntary including information that non-participation would not affect their future studies or 
careers. Written consent was given by filling out the questionnaires.  
Study II: Permission to conduct the study and to disseminate the results was granted in 
writing from each of the participating colleges. Oral and written information was given about 
the study to all participants, and it was explained that participation was voluntary and 
anonymous and that participation or non-participation would not influence further studies or 
future career. All participants gave written informed consent before the interviews started. All 
interviews were conducted in privacy. 
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Ethical approval was obtained from the regional ethical committee in Stockholm, Sweden 
(2013/415-31/4) 
Study III: Ethical permission was granted by the National Board of Health and Welfare and 
by the regional ethical committee in Stockholm (permission number 2010/1828-31/3, 23 
December 2010) to allow midwifes to independently provide medical abortion, according to 
the study protocol. After approval by the regional ethics committee at Karolinska Institutet all 
applications were publicly available. The study was registered with Clinicaltrials.gov 
NCT01612923.
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4 RESULTS 
4.1 STUDY I 
The first study showed that disallowing attitudes and misconceptions about the law were 
common among the surveyed medical students. Only thirteen percent had clinical practice in 
abortion care services. A slight majority believed that trained general nurse midwives 
(GNM) would have the capacity to provide abortions. 
Almost 2000 (1996) medical students participated in the survey on knowledge and attitudes 
to abortion, the response rate was 99%. The number of missing answers was low and 
ranged from 1.1%-2.1%. Numbers of “neither” answers ranged from 0.9 to 26.3% where 
the highest numbers stem from statements requiring specific knowledge such as “Women 
prefer to have surgical rather than medical abortion” (26.3%) and surgical abortion is more 
harmful than medical abortion (19.3%). 
The respondents socio-demographic background was relatively homogenous, 43% of the 
participants were women and 71% attended private colleges. Almost three quarters of the 
interviewees found that the reproductive health had been sufficiently covered in their 
education, and 69% percent assessed their own knowledge of the subject SRHR to be good. 
However, practical experience was rare, only 13% of respondents had any clinical training.  
	 Disagree  (%) Neither (%) Agree (%) Missing (%) 
Unsafe abortion is a serious 
health problem in India 
67	(3)	 19	(1)	 1898	(95)	 22	(1.1)	
 	 	 	 	Abortion among unmarried is 
acceptable  
397	(20)	 183	(9)	 1388	(65)	 38	(1.9)	
 	 	 	 	Abortion is morally wrong 1208	(60)	 294	(15)	 470	(23)	 34	(1.7)	
 	 	 	 	A woman should always have 
the right to an abortion  
197	(10)	 109	(5)	 1694	(83)	 36	(1.8)	
 	 	 	 	A woman needs to have her 
partner's approval to have an 
abortion 
1301	(65)	 172	(9)	 494	(25)	 39	(1.9)	
 	 	 	 	Specially trained GNMs can 
provide abortions in India  
706	(35)	 232	(12)	 1027	(51)	 41	(2.0)	
	
Table 4.1.1 Attitudes to abortion among medical students (n=1996) in Maharastra, India, 
including missing data.  
Most students agreed that unsafe abortion is a serious health problem in India (95%), but 
almost one quarter (23%) found that abortion is morally wrong. Most acknowledged that 
pre-martial sexual relationships are increasing (91%) and the majority also agreed that 
abortion among unmarried is raising (91%), but still one fifth 20% found that abortion 
among unmarried was unacceptable. See table 4.1.1 
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Figure 4.1.1 Medical students’ attitudes towards different aspects of abortion  
One quarter of the students (n= 494 (25%), 56 missing) stated that “A woman needs her 
partner, or spouses’, approval to have an abortion”. A smaller proportion of female 
respondents (n=168 (19.7%), 95% CI 17.1-22.6) than male students (n=326 (29.2%), 95% 
CI 26.6–32.0) agreed to this common statement. The intergroup analysis for place of birth 
showed that respondents born in urban areas (23.2; 95% CI 20.1-24.4) were less likely than 
students born in rural areas (32.7; 95% CI 28.7-37.0) to hold this misconception. The same 
was true for students attending private colleges (23.2; 95%CI 21.0-25.5) versus respondents 
attending government colleges (29.9; 95% CI 26.2-33.9). See Figure 4.1.2 
 
Figure 4.1.2 Student’s disagreeing to the statement “A woman needs to have her partner or 
spouse’s approval to have an abortion” inter-group analysis, %. 
Female students (n=761,89.3%, 95% CI 87.0-91-3) were more likely to agree that a woman 
should always have the right to an abortion than male students (n=932, 83.5%, 95% CI 
81.5-85.6).  
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Students who found that the topic of sexual and reproductive health had been sufficiently 
included in their education demonstrated higher awareness of the health impact of unsafe 
abortion, were more likely to agree that abortion at unregistered clinics is more harmful, 
and that unmarried women are more likely to seek abortion at unregistered clinics than 
students who had stated that their education in sexual and reproductive health was not 
sufficient. Students who assessed their own knowledge to be good or very good were more 
likely to agree that abortion at unregistered clinics is more harmful, and that a woman 
always should have the right to have an abortion than students who didn’t assess their own 
knowledge as sufficient. See table 4.1.2 
 Statements Has the topic of sexual and 
reproductive health been included 
in your programme? 
 
 How do you assess your 
knowledge of sexual and 
reproductive health? 
 
 
Not/ Some 
(n = 495) 
n (%) 
95% CI 
Adequately  
(n = 1475) 
n (%) 
95% CI 
 Poor/ Fair 
(n = 582) 
n (%) 
95% CI 
Good/ Very good 
 (n = 1382) 
n (%) 
95% CI 
Unsafe abortion is a serious 
health problem in India 
 
451 (91.5) 
88.7–93.8 
425 (97.0) 
96.0–97.8 
 
  
Abortion at unregistered 
clinics are more harmful than 
at registered clinics 
 
419 (85.3) 
81.8–88.3 
1,363 (93.2) 
91.7–94.4 
 
508 (87.9) 
84.9–90.4 
1,269 (92.6) 
91.1–94.0 
Abortion clients are treated in 
privacy in India 
 
304 (62.3) 
57.8–66.6 
1,087 (74.8) 
72.4–77.0 
 
  
A woman should always have 
the right to have an abortion in 
case of an unwanted 
pregnancy 
 
398 (81.6) 
77.8–84.9 
1,276 (87,5) 
85.6–89.1 
 
476 (82,5) 
79.1–85.5 
1,195 (87,6) 
85.7–89.3 
Unmarried women have more 
complication from abortion 
than married 
 
  
 
372 (64,2) 
60.2–68.2 
991 (72,3) 
69.8–74.6 
Unmarried women prefer to 
have abortions outside of 
public health clinics 
 
422 (85.8) 
82.4–88.7 
1,345 (91.7) 
90.2–93.1 
 
  
Abortion among unmarried are 
rising in India 
433 (87.8) 
84.6–90.6 
1,366 (93.1) 
91.6–94.3 
 514 (88,6) 
85.8–91.1 
1280 (93.1) 
91.6–91.4 
Table 4.1.2. Differences in attitudes to abortion related to the respondent’s assessment of education in sexual 
and reproductive health and assessment of own knowledge in the subject 
Slightly more than half (n= 1027(52%)) of the surveyed students agreed that trained nurse-
midwifes can provide abortion in the future. 
4.2 STUDY II 
We found that medical students in Maharastra are afraid to provide abortion in the future. 
This theme is supported by three subthemes: limited understanding of the laws regulating 
termination of pregnancy and how it is different from the law regulating the use of ultrasound 
for prenatal diagnostic purposes, experiences from the clinical setting and the influence of 
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traditional norms and values. The themes are illustrated in Figure 4.2.1. We also probed for 
students’ views on expanding the provider-base for abortion to non-physicians. 
 
Figure 4.2.1 Overview subthemes supporting the main finding that medical students in 
Maharastra are afraid to include abortion in their future practice. 
The below statement illustrates the conception of a common fear among doctors and in the 
society. 
Yah, there is a fear in the society, and even a fear in the mind of doctors. . . Maybe the fear 
in the mind of doctors comes from hearing about doctors being punished [ for doing 
abortions], therefore they are afraid to be caught doing abortions. Doing abortions can 
also harm our status in the society . . .For the woman, having an abortion, it does not affect 
the female negatively [. . .in a medical way . .] but the woman fears that if she does this she 
will be accused and her family will also be accused. Informant 3, female, private college 
4.2.1 Lack of deeper understanding of the legal regulation 
Interviewees were often aware about the content in the MTP act allowing abortion on many 
indications, but yet most concluded that abortion is illegal in Maharastra. Students were 
aware of the declining sex ratio in Mahrastra, and of the existence of the PC-PNDT law, but 
the contents of the two laws were intertwined. Government actions to limit sex-selective 
abortions were well known, and the students described a general fear among doctors to be 
prosecuted for illegal actions. The discourse was generally held from a physicians’ 
perspective not questioning the need to protect oneself from being accused of illegal 
actions. Only occasionally did students reflect on how the widespread fear among 
Fear to 
provide 
abortion
Legal
regulation
Traditional 
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Clinical 
experience 
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physicians could have negative consequences for women and ultimately impact on maternal 
mortality and one student expressed . . .  it is a fear but it should be removed.. . . 
The students described the use of common, or convenient, interpretations of the law that 
limited the woman’s possibility to have an abortion. Such delays could for instance occur by 
asking for permission from the woman’s partner or parents, or by reporting the situation to 
the police or government. 
For example, if a mother wants to do an abortion, the MTP act says that there is no necessity 
of asking her husband. But still, in India, even in hospitals, we ask the husband and we take 
the signature of husband too, because the husband may go to court and say that ‘they did not 
ask me’.  So even though the law says that after 18 years old a woman can come and she 
have the right to take abortion medicines from the doctor but still we search for the 
guardians and parents. Informant 17, man, private college. 
4.2.2 Experience from the clinic 
This subtheme is generated from of three underlying themes, that doctors are afraid to 
provide abortion, that students lack clinical skills and confidence and misconceptions about 
medical abortion.  
A dominating perception was that individual physicians avoid taking independent action. 
Many students described observing physicians doing nothing, especially in rural areas. One 
respondent described that “physicians don’t do their job…”. Reasons stated by the 
interviewees were fear of wrongdoing and lack of skills. In India respect for authority is high, 
and several accounts were about reports to the hospital authorities or even the police, 
especially in cases where unmarried women sought treatment for unintended pregnancies.  
I:  Ok: so the doctors in the rural areas just say that they are providing, but they are not 
actually telling the woman that yes, you can come and we help you with this? 
R:  Yes, they just tell the seniors that ‘we are doing this’ but really it is not done. 
R:  I have seen rural areas where there are MBBS doctors… They also refer to this 
government hospital ‘go to the city and do thi’s.  They just give painkiller, just diclofenac. 
Yes, but 2 to 3 doctors are there, they don’t pay attention that much. Informant 9, male, 
government college. 
The respondents own clinical experience was very limited. Students described discomfort and 
insecurity in contact with patients. Male students experienced that they had particular 
difficulties in communicating with female patients, especially in matters related to pregnancy 
and abortion. They also described an insecurity should they perform a vaginal exam on a 
female patient without the partner’s consent. The students’ talked openly about skipping 
postings, especially in rural areas, in order to study for the upcoming exams to gain access to 
medical specialization. 
I: So have your met any women seeking abortion in your practice so far?  
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R: I have just done my OBS-GYNE posting for 25 days, for exam purpose I skipped one 
month posting, so I have not come across that. Informant 14, female, government college. 
Medical abortion was regarded with suspicion and although most interviewees were aware of 
the mifepristone-misoprostol regime, they confused medical methods of abortion with 
emergency contraception. Many stated that mifepristone and misoprostol was illegal in 
Maharastra.  
Mam, it is banned in Maharashtra, mifepristone and misoprostol. Informant 18, man, private 
college. 
Despite concluding that women prefer medical methods of abortion the students did not trust 
women to be able to handle regimes or come for follow-up at the clinic. Fear of adverse 
events and complications was common. Dilatation and curettage was considered the method 
of choice should an abortion be provided. 
4.2.3 Influence of traditional norms and values 
This subtheme was built from the underlying themes that pre-marital sex is illegal in society 
and the respondents expressions of negative attitudes towards the rural community.  
The interviewed medical students stated that pre-marital sex and abortion are illegal in India, 
and as a consequence neither contraception nor abortion was available in India. The students 
explained that unmarried women were dependent on their partners to get access to 
contraception. Societal values affected physicians decision-making and were equaled with the 
law. This especially concerned unmarried women. Even though interviewed female students 
were highly educated and about to start their career in the medical profession, they described 
that their families influenced their choice of partner and also of future career. They expressed 
a concern about not disgracing their families. 
Abortion is illegal for unmarried women there should be more awareness and more 
knowledge about the contraceptive methods. Informant 13, male, government college. 
I don’t think a girl should come alone in the first place. I think someone should accompany 
the girl because it is a medical procedure an all. Informant 21, male, government college. 
The interviewed students experienced a social distance from the rural community. The people 
in rural areas were believed to lack knowledge and to hold poor attitudes. Students described 
being afraid of treating women as they might be threatened or punished by their family 
members. No student wished to work in the rural areas, especially not more than the 
stipulated year that might give them priority to further education. 
4.2.4 Attitudes to midlevel provision 
Most students stated that something has to be done to reduce abortion related mortality in 
India. Many held positive attitudes towards non-physician provision of medical abortion. 
Some students had experienced that nurses provided care, especially in rural areas and they 
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acknowledged nurses for their skills. Also, the nurses often had local connection, which was 
seen as an advantage. Although the question about future non-physician provision of abortion 
was seen as abstract at first, many students agreed that trained nurse-midwives could provide 
abortion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
How	to	meet	need	for	safe	abortion	provision?	
Nurses already counsel 
and even insert IUD 
Nurses	can	be	trained	to	provide	abortion	
Nurses	have	much	knowledge	
Physicians	only	should	provide	abortion	
Physicians	are	the	only	ones	with	enough	knowledge	to	provide	abortion	
Figure 4.2.4 Medical student’s thoughts about non-physician providers of abortion 
 In India I think it is good thing, because we can educate the nurses and social workers about 
the different methods, then they can definitely go to the people and tell them about different 
methods, or people can ask them about different methods instead of going to any quack they 
can prefer to go to the nurse it will definitely help them.  I think it is good. Informant 6, 
female, government college. 
Some students however were skeptical of nurse-midwives ability to provide such services 
safely. 
4.3 STUDY III 
In the RCT, the risk difference for effectiveness, complete abortion without surgical 
intervention, was 1.6% (95% CI; 0.2–3.6%, p = 0.027). This means that for every 100 treated 
women, the patients in the nurse-midwife group will undergo 1.6 fewer surgical abortions at 
follow-up than the patients treated by physicians. This can also be expressed as 0.016 fewer 
surgical interventions per procedure in the intervention arm. 
Direct costs were calculated using the information from the hospital for salaries, payroll tax 
and time of treatment. Costs for consultation with physicians were calculated based on 
physician salaries. Consultations occurred in 26% of the cases handled by nurse-midwives 
and they lasted for six minutes on average. Senior physicians were consulted in four per cent 
of the cases in the standard treatment group, those consultations lasted for an average of 14 
minutes. An assessment of the cost for patients’ time was made using the time the women 
spent with their provider. Training costs for nurse midwives was calculated using the price of 
an ultrasound course for midwives, the midwives’ salary loss and the cost of physician 
supervision of 50 subsequent ultrasounds. Thus the total direct cost per procedure was EUR 
58.3 in the standard treatment group and EUR 45 in the intervention group.  
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Although there were no significant differences in safety parameters (need for hospitalization 
or blood transfusion) between groups, we calculated the costs for complications at a per-
procedure level. In the intervention group they were 37€ per procedure, and in the standard 
care group they were 48€ per procedure. Those costs were added to the most conservative 
estimate, that took the assessed saving in waiting time for the next-coming patient.  
ICER was calculated for total direct costs (-831,2), direct costs including the reduced waiting 
time for the next patient (-1081.2) and for total direct and indirect costs (-1768.8) using the 
risk difference per procedure as denominator. 
To obtain a sensitivity estimate we calculated the ICER for the upper and lower range of the 
95% CI (95% CI; 0.2–3.6%). The results all fell within quadrant IV in the cost-effectiveness 
plane. Figure 4.3.1 
 
Figure 4.3.1 Illustration of sensitivity analysis using upper and lower limits for 95% CI for 
the risk difference of efficacy. 
An important finding from the parent study was that there was a significantly higher number 
of women randomized to nurse-midwives (290/532) than randomized to physicians (241/528) 
that had a long-acting reversible contraceptive inserted within three weeks of the abortion 
(95% CI 3.2 to 15.2%).  
4.4 STUDY IV 
4.4.1 Search results 
The search identified 8939 unique citations. After screening for titles, abstracts, and in 20 
cases full articles, five papers from four randomized controlled studies (Cleeve et al., 2016; 
Klingberg-Allvin et al., 2015; Kopp Kallner et al., 2014; Olavarrieta et al., 2015; Warriner et 
al., 2011) and one article from a prospective cohort study (Jejeebhoy et al., 2012) were 
included. 
4.4.2 Characteristics of included studies 
The studies were conducted in varying settings and included different provider types. All 
studies on medical abortion used a mifepristone and misoprostol regimen, and the 
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randomized controlled trial on medical treatment of incomplete abortion used 600mcg 
misoprostol orally. All providers in one study used the same treatment. 
4.4.3 Outcome measures 
4.4.3.1 Effectiveness 
The definition of effectiveness used in all studies was complete abortion without need for 
vacuum aspiration. Completion was determined by clinical assessment of, in addition one 
study also used a urinary pregnancy test (Kopp Kallner et al., 2014), and one study abdominal 
ultrasound (Olavarrieta et al., 2015). 
Intention to Treat (ITT) risk estimates (RR 0.99, 95% CI 0.96 to 1.02) reported in three RCTs 
were used to conduct meta-analyses for effectiveness (Klingberg-Allvin et al., 2015; 
Olavarrieta et al., 2015; Warriner et al., 2011). Effectiveness is equivalent between provider 
groups. Subgroup analyses indicate that complete abortion rates may be similar between 
provider groups regardless of whether women are being treated for induced or incomplete 
abortion. The certainty of evidence is moderate.  
4.4.3.2 Safety 
Only one serious adverse event was registered (Olavarrieta et al., 2015). The included studies 
were large but as adverse events due to abortion are rare, they were not powered to detect 
safety differences. Clearly defined safety outcomes were only reported in one study, and one 
recorded adverse events for reporting on safety  (Kopp Kallner et al., 2014; Olavarrieta et al., 
2015). The prospective cohort study reported on hemorrhage requiring blood-transfusion or 
hospitalization.  
4.4.3.3 Acceptability 
Acceptability and/ or satisfaction with treatment and/or services was reported by three RCTs 
(Cleeve et al., 2016; Kopp Kallner et al., 2014; Olavarrieta et al., 2015). The meta-analysis 
shows an effect estimate (RR1.11, 95%CI 0.90 to 1.36) for women treated by non-physicians 
who would recommend treatment/ provider to a friend or prefer the same provider should she 
need a treatment in the future. The certainty of evidence is low.  
The meta-analysis for overall satisfaction, two RCTs (Cleeve et al., 2016; Olavarrieta et al., 
2015) show that women probably are equally satisfied regardless of provider allocation (RR 
0.99, 95% CI 0.93 to 1.06). The certainty of the evidence is moderate. Figure 4.4.3.3.2. 
  40 
 
Figure 4.4.3.3.2 Analysis 2B. Acceptability. Overall satisfaction  
4.4.3.4 Conclusion 
This study confirmed that the effectiveness of non-physician provision of medical abortion 
and medical treatment of incomplete abortion is probably similar as the effectiveness of 
treatment by physicians. Also, women’s overall acceptability with the provider was probably 
similar for non-physician and physician providers. 
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5 DISCUSSION 
The overall aim of this thesis is to study factors that influence access to comprehensive 
abortion care focusing on increasing provider availability in different settings. Each of the 
four included studies explored factors influencing provision of, and treatment for abortion 
including post abortion care.  
The first study showed that disallowing attitudes and misconceptions about the law were 
common among medical students in Maharastra India. Despite the curriculum emphasis on 
practical education only thirteen percent had any clinical practice in abortion care services. 
General nurse midwives (GNMs) were believed to have the capacity to provide abortions 
by a slight majority (Sjostrom et al., 2014). Those attitudes were confirmed by in-depth 
interviews performed among medical students in Maharastra. The interviewees were afraid 
to include abortion provision in their future practice and lacked ability to independently 
interpret the law regulating abortion, confusing it with the law regulating pre-natal 
determination of fetus sex. The students perceived a social distance from future patients, 
especially from rural areas, and their views and actions were influenced by traditional 
norms and values (Sjostrom, Essen, et al., 2016). 
The cost-effectiveness analysis of nurse-midwife treatment for first-trimester medical 
abortion showed that the direct cost per procedure was EUR13.3 cheaper than the standard 
treatment by physicians. Applying incremental cost effectiveness ratios showed a saving of 
EUR 831 per avoided surgical intervention(Sjostrom, Kopp Kallner, et al., 2016). 
The fourth study concluded that the effectiveness and women’s acceptability of non-
physician provision of medical abortion and medical treatment of incomplete abortion was 
similar as when treated by physicians (Sjöström et al. Manuscript)  
These findings all illuminate important aspects on access to safe abortion care that are 
important to consider in all types of settings ranging from low income contexts with 
restrictive legal frameworks to high income settings where abortion is permitted on wide 
indications. 
5.1 CONCEPTUAL FRAMEWORK REVISITED 
Considering the multitude of previously suggested definitions of access to healthcare, and 
their associated conceptual frameworks presented in the limited overview of frequently used 
frameworks in chapter 1.6, the difficulty to develop a comprehensive model that includes all 
aspects that may influence access is apparent. It is, however, important to distinguish between 
supply side factors that are generally easier to understand and influence using health systems 
and policies, and demand side factors that are broader in scope and include aspects such as 
equity and acceptability that are more immediately related to the context thus may be more 
difficult to pinpoint.  In the light of the above overview of contextual frameworks, I present a 
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simplified model to illustrate how the findings of this thesis contributes to the evidence of 
needs for improvement to ensure access to comprehensive abortion care. Figure 5.1 
 
Figure 5.1 A simplified framework for access 
The context is the most important determinant of whether access is achieved and it affects 
both the supply and the demand of abortion care. The supply side is influenced by “hard” as 
well as “soft” factors. Hard factors, such as implementing more cost-effective health-care 
units using nurse-midwife providers of abortion, are relatively easy for the health system to 
implement. But the existence of such clinics does neither imply that service is provided, nor 
that patients seek care. Acceptability of services is probably the most important factor from 
the demand side perspective and determines care seeking behavior for comprehensive 
abortion care. In order to reach through the contextual framework and change care-giving and 
care-seeking behavior policymakers need to focus on education of care-givers as well as 
women. 
5.1.1 Context 
To study access to health care you have to understand the context. The context includes 
CONTEXT 
SUPPLY 
DEMAND 
Cost 
effective 
treatment 
Provider 
attitudes 
Acceptability 
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factors that influence care-seekers and providers alike such including geography and religion, 
social structures, power-hierarchies, levels of education Studying a specific area of access 
such as abortion, the importance of the context is augmented due to gendered structures and 
stigma. Equity can be seen as a function of the context reflecting real or perceived social 
distances as well as education levels and differences between the sexes. 
We found that medical students in Maharastra perceived a social distance between 
themselves and people in rural areas (Sjostrom, Essen, et al., 2016). Such social barriers are 
grounded in the context and have negative impact on access to health care. However, access 
can be increased by reducing the distance between care-givers, health care systems and their 
users. A study among sex-workers in Uganda found that measures at the community-level, 
including a support network among women where they can speak openly about abortion, 
training of peer educators and community outreach workshops on abortion increased the 
probability that women would access safe abortion services. On the health facility level the 
same study concluded that it is important to ensure that providers treat women with care and 
respect, allowing them to be accompanied within the facility and guaranteeing their 
confidentiality (Marlow et al., 2014). 
5.1.2 Supply side aspects on abortion access 
There are many perspectives on provision of abortion. The evidence confirming that nurse-
midwife provision of medical abortion in the first trimester is cheaper than provision by 
physicians’ form a base on the supply side of access (Sjostrom, Kopp Kallner, et al., 2016). 
Adding the results from the studies on medical students’ attitudes toward abortion showing 
that although students were aware of the substantial impact of unsafe abortion on maternal 
mortality, they were not willing to provide abortions due to fear of consequences and stigma 
makes it easy to conclude that a shift toward non-physician provision is needed (Sjostrom, 
Essen, et al., 2016). Non-physician provision has become a means to increase the provider-
base for comprehensive abortion care, especially where availability of physicians is scarce 
but also in settings where there is an unwillingness among physicians to provide reproductive 
health services but there is no evidence confirming that non-physicians hold more permitting 
attitudes toward provision of abortion. On the contrary a literature review from sub-Saharan 
Africa and South-east Asia identified nine themes that influenced health-care providers of 
different cadre’s, including physicians, nurses and midwives, attitudes and perceptions 
toward abortion. Providers were generally supportive of abortion in case of rape or in order to 
save the woman’s life, but there was a widespread uncertainty about abortion laws. Women 
were condemned and nurses and midwives stated that they disliked providing abortion 
services. Medical abortion was preferred by providers in some studies as less involvement 
from the care-giver was needed (Rehnstrom Loi et al., 2015). 
5.1.3 Acceptability 
The systematic review showed that women’s acceptability of treatment for medical abortion 
by non-physician providers probably is similar to provision by physicians. Acceptability is a 
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multi-dimensional component of care seeking behavior and based on patient-provider trust. 
The WHO concludes that acceptability requests all health facilities, goods and services to be 
respectful of medical ethics and culturally appropriate as well as sensitive to gender and life-
cycle requirements (WHO). Acceptability reflects the contextual adaptation of services, the 
patient-provider relationship and the judged appropriateness of care (Cleeve et al., 2016) 
Barriers caused by low acceptability and trust are more likely to affect the care-seeking 
behaviors, and thus access to care, of socially disadvantaged groups in different settings 
(Gilson, 2007). Despite the importance of acceptability for access to health care, it is  a 
poorly conceptualized component of access to health care (Dillip et al., 2012).  
Gilson includes the importance of a shared interface of health-beliefs, communication and 
infrastructure (Gilson, 2007). A factor that affects the relationship between care-giver and 
care-taker is perceived or real social distance. We hypothesize that the social distance 
between abortion seeking women in relation to nurse- midwives may be smaller in relation to 
their distance to physicians, thus increasing the fit, but evidence of this is scarce. Women’s 
level of education influences their understanding about when to seek care and empowers 
them in the patient-provider relationship thus increasing acceptability.  
5.2 MISCELLANEOUS OBSERVATIONS 
Although determining cost-estimates for the differences in prescription and administration of 
long acting reversible contraception between nurse-midwives and physicians was beyond the 
scope of our cost-effectiveness study, it is a very important finding. Providing contraception 
and especially long acting contraception at the time of an abortion or treatment for post-
abortion care is often neglected. Despite years of advocacy, maternal mortality due to 
unplanned pregnancies and abortion is still high. In order to reduce maternal mortality, it is 
important to work with preventive measures and use the opportunity when women seek care 
to educate and inform about contraception. In addition to the reduction in unplanned 
pregnancies and related maternal mortality, the health system cost of LARCs is lower 
compared to other contraceptives (Trussell et al., 2015). 
A recent retrospective cohort study reviewed medical records of 987 women who sought an 
abortion in 2009. Twenty-four percent of the included women requested a repeat abortion 
before the end of the follow-up period, the end of December 2012. Those who had chosen 
long-acting reversible contraception (LARC) when they underwent the first abortion had 
fewer repeat abortions (Kilander et al., 2016). The importance on immediate or early start of 
a LARC method post medical abortion in reducing subsequent unplanned pregnancy have 
also confirmed in randomised controlled trials (Hognert et al., 2016; Saav et al., 2012). 
A component of access that is not discussed in any frameworks I have studied is the role of 
the industry. The industry can take a lead on making contraceptives available at affordable 
prices in all settings. Representatives from the industry also has the power to influence 
governments. As the interest for CSR is increasing in the business community, As the interest 
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for CSR is increasing in the business community, the scientific community needs to 
collaborate with the pharmaceutical industry also in this aspect.  
5.3 METHODOLOGICAL CONSIDERATIONS 
5.3.1  Study I  
The large number of respondents representing 47.5% of students at private colleges and 26% 
of students at government colleges and the 99% response rate is the major strength of the first 
study. Also the students’ recorded knowledge, perceptions and attitudes reflect the content of 
their basic education program.  
Reliability, whether results are consistent over time, is confirmed by the qualitative results 
from Study II.  
External validity, whether the results be generalized to settings beyond the original study, is 
difficult to confirm, even within India, due to its’ diverseness. However, in this study, the 
sociodemographic background of the respondents was relatively homogenous which may 
make results transferable at least to medical students within the state of Maharastra.  
Internal validity describes how well a study measures what it is supposed to measure, and 
may have been affected by the design of the study instrument and the selection of 
participants. The questionnaire had previously been developed, tested and used in Vietnam 
using the Knowledge Attitude Perceptions (KAP) tool format. The original study aimed to 
measure midwifery students’ values and attitudes on adolescent sexuality and abortion. It was 
altered to suit the Indian setting and to measure medical students’ attitudes to sexual and 
reproductive health with a special focus on contraception and abortion. Evaluation of 
practices were not included in the questionnaire as the students were not involved in any 
independent practice. Pre-testing or piloting of the adapted survey was not deemed possible 
since the workshop in CAC only took place once yearly.  
The KAP survey format has been used in the field of family planning since the 1950s as data 
collection is anonymous and thus suitable for sensitive topics. Within the UN, KAP surveys 
are often used to reveal misconceptions and misunderstandings that may indicate potential 
barriers to implement behavior change. One reason KAP surveys are popular is the relatively 
simple design and analysis. It can be questioned whether KAP survey results are truly valid 
and generalizable. One limitation of KAP surveys is that respondents tend to give answers 
that they believe are correct, acceptable or appreciated (Launiala, 2009). This may have 
biased our results as students in India are unaccustomed to question seniors or teachers. To 
avoid such bias we used positively and negatively worded statements. A strength was that the 
questionnaires were answered anonymously and in writing without the use of an interpreter.  
Using scales in surveys have limitations and our results may be affected by bias due to social 
desirability as well as cultural factors. Cultural differences in how responses are marked on a 
Likert scale has previously been shown to influence responses when comparing respondents 
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with different sociodemographic backgrounds (Lee et al., 2002). Also the use of a “neutral” 
statement may influence results negatively. 
A clear sectioning of questions designed to measure attitudes, perceptions and knowledge 
was not made for the final version of the instrument, and specific statements designed to 
measure knowledge were only available for the topic contraception. on abortions were mainly 
designed to measure attitudes, defined as “ the way you feel or think about someone or 
something” (Marriam-Webster), whereas perceptions “the way you think about or understand 
someone or something” (Marriam-Webster). 
Additional questions in the study instrument could have further clarified matters such as the 
importance of family values, the influence of relatives on women's and practitioners' decision 
making, and practitioners' perceptions of legislation regulating abortion.  
Selection bias may have occurred as we included colleges where the local collaborating NGO 
was represented, and the questionnaire was distributed before a lecture covering the subject 
of reproductive health.  
5.3.2 Study II 
The second study was initiated and planned after the first results from Study I became 
available. A topic guide was developed using an emergent design. All interviews were 
performed by myself, in English, which gives the study unique strength. The collaborating 
NGO facilitated contact with presumptive colleges and their administration. I also visited the 
NGO’s local office in Maharastra and acquired additional information regarding the CAC 
workshop and the participating colleges.  
Trustworthiness, described as credibility, dependability and transferability, was sought 
throughout the research process (Lincoln et al., 1985). Credibility reflects the focus of the 
research. It can be strengthened by ensuring a selection of participants with different 
perspectives as well as through the use of an appropriate method for data collection and the 
accumulation of a correct amount of data. Credibility is also strengthened by the use of 
suitable meaning units and ensuring that categories and themes cover data. How similarities 
and differences within and between themes and categories are judged are other factors that 
affect credibility (Graneheim et al., 2004). A key-informant was used ensure that the sampled 
students represented as different socio-demographic, cultural and religious backgrounds as 
possible. Selection bias can have occurred due to the key informant, and at one college the 
dean told me I was lucky because I was to meet with their top student. Data collection 
continued until saturation, when occurs when no additional information is generated. This 
strategy ensures that the correct amount of data is gathered. Meaning units, categories and 
themes were discussed and agreed upon by all co-authors. The meaning of what was said was 
summarized and confirmed with the respondent, this approach was chosen since the students 
were in transition to other postings and would be unreachable for member check Quotes were 
used to illustrate the different themes.  
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Confirmability, the degree to which results can be confirmed by others, was sought by 
summarizing and re-confirming the meaning of what was said with the respondent at the time 
of the interview. Dependability describes how data changes over time and reflects changes in 
the researcher’s decisions throughout the process of analysis. We used an emergent design 
and applied new insights from one interview in the next to deepen the knowledge. Changes in 
the topic guide was discussed and confirmed within the research team including aspects 
regarding how similarities and differences of content is consisting over time.  
Transferability refers to whether findings can be transferred to other settings or groups. 
Considering the diversity of Indian states, it is impossible to draw conclusions about the 
transferability of results, even within the country. To facilitate and enlighten the process of 
transferability we included descriptions of the present culture and context, selection process 
and characteristics of participants, data collection and analysis. Although heterogeneous 
sampling was conducted the results of our study only reflect the present context. 
Construct and content validity was assured through the main researchers pre-understanding of 
the context and use of field notes to add richness to data and constructs, as well as the 
emerging study design with constant revision of the study instrument.  
Reflexivity reflects how the researcher’s personal characteristics influences the results (Green 
2009). Although I had spent several years in India at the time of the interviews and was 
familiar with language and culture, I was still a middle aged, blonde, Caucasian woman and 
as an Obstetrician-Gynecologist, in a superior position to the students, which probably, but 
not necessarily, affected the results. I perceived that it was intimidating to some interviewees 
at first to speak openly to me, especially as hierarchies are very important in Indian society. 
However, I believe I managed to have an honest and open dialogue with most respondents 
through an open and permitting conversation. Possibly bias was reduced because I did not 
come from the context, and one dean told me that the interviewed students were very happy 
after the interviews and had said that no-one had talked with them like this before, implying 
that they were invited to an open dialogue and listened to with respect. 
5.3.3 Study III 
The purpose of health economic evaluation is a to provide information to help decision-
makers in situations with limited resources. Over the years increasingly sophisticated 
methods have been developed, which in turn has made interpretation of findings more 
complicated. It has been shown that economic evaluations have limited influence on health 
care decisions, which is due to complexity (Eddama et al., 2008). 
Sampling: The strength of the present study is the solid assessment of both the cost and the 
effectiveness component. The simplicity of calculations of costs and effectiveness adds to 
easy understanding of the evidence for decision-makers and other stakeholders.  
One can argue that effectiveness, assessed in trials that are conducted in routine clinical 
practice on outcomes essential for clinical decisions and analyzed Per Protocol (PP), are a 
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better denominator than efficacy describing the effect of an intervention observed under ideal 
circumstances  and analyzed according to Intention To Treat (ITT) (Gerald Gartlehner, 2006). 
The present study was based on an efficacy trial, that trial was conducted in a real clinical 
setting but analyzed for ITT. In this case, the distinction between efficacy and effectiveness 
was deemed to be subordinate and not considered for the outcome of the study. 
Method: Cost effectiveness analysis (CEA) is an established method to compare costs and 
effects of interventions when there is a difference in effectiveness. It is recommended to 
report results as incremental cost-effectiveness ratios (ICER) National Institute of Health and 
Care Excellence guidelines (NICE). A criticism against the use of ICER’s is that ratios does 
not inform on the number of treatments considered. In addition, the ICER for the case when 
both the cost and the efficacy of an intervention are increased (Quadrant II in the CE plane, 
figure 3.2.3) may have the same numeral value as in the opposite case, when the intervention 
is cheaper and less efficacious, which is represented in the diagonally opposite quadrant 
(quadrant III). These two scenarios have a different interpretation and implication 
(Drummond MF, 2005). It has been argued that in cases where the intervention dominates, ie 
where the intervention is more effective and less costly than the standard treatment, applying 
ICER produces no additional information(Stinnett et al., 1997). Other sources consider such 
results to be part of the findings and should be reported to illustrate the full picture (Sacristan 
et al., 1997).  
Using cost-minimization (CMA) analysis could have been considered as the study was 
conducted alongside a randomized controlled equivalence study, but whenever there is  
difference in clinical effectiveness, it is deemed necessary to estimate incremental cost-
effectiveness, one argument being that a substantial proportion of studies reporting ‘negative’ 
results really have insufficient power to detect differences in treatment effect (A. H. Briggs et 
al., 2001) (Dakin et al., 2013).  
Should a cost-utility analysis have been conducted? A cost utility analysis considers the 
quality-adjusted life years (QUALY) added by an intervention. QUALYS are determined 
using a health-utility index developed from rating-scales, standard gamble or time trade-off 
(Santerre RE, 2007). Using such estimates add complexity and insecurity to the economic 
evaluation (Brousselle et al., 2011). Furthermore, when looking at treatment for abortion, 
there is no evidence that such treatment affects a woman’s life negatively in the long run. On 
the contrary, longitudinal birth-cohort study found no association between abortion under the 
age of 18 and common psychiatric disorders or adverse health outcomes related to risk-taking 
behavior. Women who had undergone a first trimester abortion were not more likely to seek 
psychiatric care than women who had not undergone abortion (Munk-Olsen et al., 2011). 
Also, women who had undergone abortion were more well educated and less likely to be 
dependent on welfare than those who gave birth (Leppalahti et al., 2016). A longitudinal 
study covering 60 years and including North-American women concluded that unintended 
pregnancies were strongly associated with mental health disorders later in life (Herd et al., 
2016). 
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The economic burden of abortion seeking women was not considered. The conduct such an 
evaluation would have required collection of socio-economic data as well as direct costs such 
as costs for transportation and childcare but also opportunity costs such as days of missed 
work or education. On the other hand, such costs would have been the same across groups. 
The economic consequences of the finding that women randomized to doctors were 
significantly more likely to choose home administration of misoprostol was not evaluated, 
nor was the economic consequences related to that women in the nurse-midwife group had 
LARCs inserted significantly more often than women in the physician group.  
Given the simplicity of the included parameters we could also have used a simplified method 
such as an estimate of cost, which is recommended by the NICE guidelines in cases where  an 
intervention is associated with better health outcomes and fewer adverse effects (NICE). 
Sensitivity analysis is generally recommended in health economic calculations. It is also 
argued that such analyses does not resolve methodological issues due to assumptions made in 
the model such as bias in scores used to calculate parameters such as (QUALYs), and rates 
for discounting of costs and effects (Brousselle et al., 2011). While confidence intervals for 
cost-effectiveness ratios are a valid approach to addressing uncertainty in CEA, presentation 
becomes difficult when the ICER is negative (Stinnett et al., 1997). To illustrate this the 
uncertainty can be presented on the cost-effectiveness plane (Altman et al., 1995; A. Briggs et 
al., 1998),  
5.3.4 Study IV 
The study was conducted in accordance with the WHO guideline development tool using the 
Cochrane handbook for systematic reviews (Higgins JPT) and the PRISMA guidelines.  
The quality of evidence was assessed using the GRADE system for each outcome (Grades of 
Recommendation, Assessment, Development and Evaluation Working Group). This 
approach defines the quality of a body of evidence considering methodological quality, 
directness, heterogeneity, precision of the effect and risk of publication bias. Four levels of 
quality are specified. The highest rating “high”, can only be given to evidence from 
randomized controlled trials. The evidence can be downgraded for each of the factors defined 
by the GRADE criteria. The lowest level of quality “very low” is given to studies with critical 
problems and unsystematic clinical observations. 
Bias implicates that a study contains a systematic error. Imprecision on the other hand means 
that random errors may have occurred. As a study might be unbiased despite a systematic 
error, it is common practice to assess risk of bias. Selection bias is systematic differences 
between study groups. Such differences can be avoided by sequence generation and blinding 
which was undertaken in all included RCTs, thus there was no risk of selection bias in 
included studies. No included studies were blinded by provider type, neither were outcome 
assessors, thus there is risk of performance bias, systematic differences in the care between 
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groups, and detection bias, differences in outcome assessment between groups. Attrition bias, 
incomplete outcome data, was adequately addressed in three RCTs (four reports). 
Selective reporting bias occurs when dissemination of research findings is influenced by the 
nature and direction of results. It is equally important to report from studies with non-
significant results are as important. Bias due to such incomplete reporting can be reduced by 
asking trial authors open-ended questions. In this study the WHO guideline development 
group had close collaborations with experts in the field from all regions which might have 
increased the possibility that all unpublished studies were accounted for. Not blinding the 
authors when assessing studies might also have influence on risk of bias.  
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6 CONCLUSION 
Despite of decades of efforts to reduce maternal mortality it is estimated that almost 300 000 
women die each year due to complications related to pregnancy and childbirth, around eight 
percent of those deaths are caused by unsafe abortion. This proportion of maternal deaths is 
easily preventable using contraception and comprehensive abortion care, but progress in 
reducing those deaths is slow. 
The context is an important determiner of access to comprehensive abortion care. When 
communicating research findings, it is important to reflect on who the audience is. 
Developing increasingly complex explanation models is not necessarily a way to create 
understanding among stake holders such as politicians and health system executives and 
clinicians.  
Our studies of medical student attitudes, although not necessarily generalizable to other 
settings, show that attitudes influence intentions to provide abortions and we conclude that it 
is necessary to educate and conduct values clarification in order to secure future abortion 
providers. Increasing knowledge and improving attitudes is a continuous process and 
continued education in peer networks is important also for established health care providers. 
The systematic review of midlevel provision of medical abortion and medical treatment of 
incomplete abortion added the evidence that such treatment is as acceptable to women as 
provision by physicians. Women’s acceptability of services is crucial when aiming to 
increase access to comprehensive abortion care and provides further support for 
implementation of midlevel provision of comprehensive abortion care. 
In order to improve access to safe abortion care, it is necessary to increase knowledge among 
providers and women. Further expansion of the provider base for safe abortion is possible by 
including trained non-physicians or midlevel providers. This approach is cost-effective, 
effective and acceptable to women.  
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7 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Oplanerade graviditeter har förekommit sedan urminnes tider och kvinnor har använt sig av 
en rad olika metoder för att avbryta en oönskad graviditet. Trots att det idag finns mycket 
kunskap om både om abort och preventivmetoder dör uppskattningsvis  23000 kvinnor till 
följd av osäkra aborter årligen i världen, de flesta i världens fattigaste områden framförallt i 
Afrika söder om Sahara.  
Abort är en direkt följd av oplanerade graviditeter som kan förebyggas om det finns 
tillgängliga preventivmedel. Medicinsk abort och medicinsk behandling för inkomplett abort 
med prostaglandinanalogen misoprostol är säkert, billigt och fungerar bra även där tillgången 
till sjukvård är begränsad. Misoprostol är tillgängligt i de flesta områden i världen för 
behandling av magsår, och så kallad ”off-label” användning för behandling av gynekologiska 
och obstetriska tillstånd är vanligt. Icke-läkare kan, efter träning, på säkert sätt tillhandahålla 
abort och behandling för inkomplett abort. 
Tillgängligheten till säker sexuell och reproduktiv hälsa är avhängig av en mängd faktorer 
som berör både tillgång och efterfrågan på hälsovård, nedan presenteras några av dessa.  
Indien har en stor andel av världens mödradödlighet trots att man länge arbetat för att 
förbättra förhållandena. För att säkra tillgången till familjeplanering, preventivmedel och 
abort är det fastställt att läkarutbildningen skall ha ett fokus på teoretisk och praktisk kunskap 
i familjeplanering och sexuell och reproduktiv hälsa. Trots det saknade läkarstudenter i 
Maharastra i västra Indien praktisk erfarenhet och kunskap. Det leder bland annat till 
missuppfattningar om regelverket för abort och okunskap om tillgängliga metoder. Många 
uppfattar att abort är moraliskt fel, framförallt för unga och ogifta kvinnor. När dessa brister i 
utbildningen vägs samman med traditionella värderingar och rädsla för att göra fel väljer 
studenterna att avstå att tillhandahålla abortvård. 
Vi gjorde en kostnadseffektivitetsanalys som visade att abortvård i Sverige tillhandahållen av 
barnmorskor är billigare än när den tillhandahålls av läkare. En tidigare studie  från samma 
sjukhus visade att vården som tillhandahålls av barnmorskor är lika säker och effektiv som 
när patienten träffar en läkare. Eftersom de flesta länders hälso- och sjukvårdssystem har 
begränsade budgetar är det viktigt att kunna påvisa billigare metoder med samma effektivitet. 
En systematisk översikt visade att medicinsk abort och medicinsk behandling för inkomplett 
abort tillhandahållen av sjuksköterskor och barnmorskor är lika acceptabel för kvinnor som 
läkarvård. Att en medicinsk behandling är acceptabel för patienten är en viktig komponent i 
tillgängligheten, om kvinnor uppfattar behandlingen eller vårdgivaren som oacceptabel 
riskerar man att de söker vård hos outbildade eller traditionella vårdgivare vilket kan medföra 
allvarliga hälsokonsekvenser. 
Ökad tillgänglighet till säker abortvård är ett sätt att snabbt minska den globala 
mödradödligheten. Att öka antalet vårdgivare är ett steg för att åstadkomma förbättring. Våra 
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studier pekar på hur viktigt det är med utbildning och kunskap för att säkra tillgängligheten 
till säker abortvård. Att kvinnor upplever vården som acceptabel är en förutsättning för att de 
skall söka vård på etablerade kliniker. Eftersom tränade sjuksköterskor och barnmorskor kan 
tillhandahålla abortvård som är lika effektiv och acceptabel för kvinnor som läkarvård mer 
kostnadseffektivt är det viktigt att utöka vårdgivarbasen och därmed tillgängligheten av säker 
abortvård i olika miljöer. 
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